CURRICULUM VITAE: Dott. Carlo Salvarani Data di nascita: 14 ... - Sir
CURRICULUM VITAE: Dott. Carlo Salvarani Data di nascita: 14 ... - Sir
CURRICULUM VITAE: Dott. Carlo Salvarani Data di nascita: 14 ... - Sir
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>CURRICULUM</strong> <strong>VITAE</strong>: <strong>Dott</strong>. <strong>Carlo</strong> <strong>Salvarani</strong><br />
<strong>Data</strong> <strong>di</strong> <strong>nascita</strong>: <strong>14</strong> novembre 1954.<br />
Luogo <strong>di</strong> <strong>nascita</strong>: Reggio Emilia, Italia.<br />
In<strong>di</strong>rizzo:<br />
Casa: Via Dal Verme N3, 42100 Reggio Emilia, Italia.<br />
Lavoro: Servizio <strong>di</strong> Reumatologia, Azienda Ospedaliera Arcispedale S.Maria Nuova,<br />
V.le Risorgimento N 90, 42100 Reggio Emilia, Italia.<br />
Titoli:<br />
Laurea in Me<strong>di</strong>cina, 1980, Università <strong>di</strong> Parma.<br />
Specialista in Me<strong>di</strong>cina Interna, 1985, Università <strong>di</strong> Parma.<br />
Specialista in Reumatologia, 1989, Università <strong>di</strong> Ferrara.<br />
Onori:<br />
Laurea, Magna cum Laude, 1980, Università <strong>di</strong> Parma.<br />
Specialista in Reumatologia, Magna cum Laude, 1989, Università <strong>di</strong> Ferrara.<br />
Speaker invitato (1997), Divisione <strong>di</strong> Reumatologia, Mayo Clinico<br />
Presidente 8th International Congress on Behçet's <strong>di</strong>sease (Reggio Emilia 1998)<br />
1<br />
Attività Postlaurea (per specifiche attività lavorativa nel Servizio Sanitario ve<strong>di</strong><br />
allegato stato <strong>di</strong> servizio):<br />
1980-81: Interno, 2" Divisione <strong>di</strong> Me<strong>di</strong>cina Interna, Arcispedale S.Maria Nuova, Reggio<br />
Emilia.<br />
1981-82: Assistente a tempo pieno, Divisione <strong>di</strong> Me<strong>di</strong>cina, Ospedale S.Anna, Castelnuovo<br />
Monti<br />
(RE).<br />
1982-96: Assistente a tempo pieno, 2" Divisione <strong>di</strong> Me<strong>di</strong>cina Interna, Unità<br />
Reumatologica, Arcispedale . S.Maria Nuova, Reggio Emilia.<br />
Dal 8-1-1993 al 7-1-1994 comandato presso la Divisione <strong>di</strong> Reumatologia, Mayo Clinic,<br />
Rochester, MN, USA per aggiornamento in clinica e epidemiologia delle artriti<br />
infiammatorie e vasculiti. Successivamente perio<strong>di</strong> perio<strong>di</strong> si stu<strong>di</strong>o della durata <strong>di</strong> 6-8<br />
settimane negli anni 1994, 1995, 1996, 1998, 1999,2000,2001, 2003, 2004, 2006, 2007,<br />
2008, 2009, 2010, 2011 come "Visiting Clinician" investigatore principale <strong>di</strong> progetti <strong>di</strong><br />
ricerca clinici sulle vasculiti (ve<strong>di</strong> per i progetti collaborazioni scientifiche)<br />
1996- tutt'oggi: Me<strong>di</strong>co 2 livello Dirigenziale Reumatologia e quin<strong>di</strong> Direttore, Struttura<br />
Complessa <strong>di</strong> Reumatologia, Arcispedale S.Maria Nuova, Azienda Ospedaliera <strong>di</strong> Reggio<br />
Emilia.<br />
Attività <strong>di</strong>dattica presso Scuole <strong>di</strong> Specialità<br />
Per gli anni 2007-2008, 2008-2009, 2009-2010, 2011-2012 contratto insegnamento<br />
integrativo “Le vasculiti dei grossi vasi” a titolo oneroso <strong>di</strong> ore 5 annuali presso la Scuola<br />
<strong>di</strong> Specializzazione <strong>di</strong> Reumatologia dell’Università <strong>di</strong> Bologna<br />
1
Società me<strong>di</strong>che <strong>di</strong> appartenenza:<br />
Società Italiana <strong>di</strong> Reumatologia (membro del Consiglio Direttivo dal 2004 al 2007).<br />
Società Italiana <strong>di</strong> Me<strong>di</strong>cina Interna.<br />
American College of Rheumatology (International Member).<br />
Altre Attività:<br />
Revisore <strong>di</strong> Riviste Internazionali:<br />
Journal of Rheumatology<br />
Clinical and Experimental Rheumatology<br />
Arthritis & Rheumatism<br />
Arthritis Care & Research<br />
Scan<strong>di</strong>navian Joumal of Rheumatology<br />
Rheumatology<br />
The Annals of Rheumatic Diseases<br />
Me<strong>di</strong>cine<br />
JAMA<br />
Circulation<br />
Lancet<br />
New England Journal of Me<strong>di</strong>cine<br />
E<strong>di</strong>torial Board<br />
Arthritis Care & Research<br />
Clinical and Experimental Rheumatology (E<strong>di</strong>tor of the Supplement on Vasculitides)<br />
Current Opinion in Rheumatology<br />
Principali interessi scientifici:<br />
Vasculiti (in particolare arterite temporale, malattia <strong>di</strong> Takayasu, malattia <strong>di</strong> Behçet e<br />
vasculite isolata del sistema nervoso centrale)<br />
Spon<strong>di</strong>loartriti (in particolare artropatia psoriasica, artrite enteropatica e spon<strong>di</strong>lite<br />
anchilosante)<br />
Polimialgia reumatica, sindrome RS3PE e artrite reumatoide dell'anziano<br />
Trials clinici<br />
Collaborazioni scientifiche attive (membro nazionale/internazionale):<br />
Divisione <strong>di</strong> Reumatologia e Diagnostica Vascolare, Mayo Clinic, USA: Polimialgia<br />
reumatica e Arterite Temporale<br />
2<br />
Divisioni <strong>di</strong> Reumatologia e Diagnostica Vascolare, Dipartimento <strong>di</strong> Patologia, Mayo Clinic,<br />
USA: vasculite del sistema gastrointestinale<br />
Divisioni <strong>di</strong> Reumatologia , Neurologia, e Diagnostica vascolare, Dipartimenti <strong>di</strong> Patologia<br />
e <strong>di</strong> Statistica, Mayo Clinic, USA: Vasculite isolata del Sistema Nervoso Centrale<br />
The European Collaborative Study on Inflammatory Bowel Disease: Manifestazioni<br />
2
muscolo-scheletriche delle malattie infiammatorie intestinali<br />
Progetto ITAKA (Italian Takayasu arteritis) (Mari Negri, Villa Camozzi): Arterite <strong>di</strong><br />
Takayasu nella popolazione Italiana<br />
Polymyalgia Rheumatica and Giant CelI Arteritis Intemational Study Group: criteri<br />
<strong>di</strong>agnostici della Polimialgia Reumatica<br />
ASsessment in Ankylosing Spondylitis (ASAS) Working Group: definizione <strong>di</strong> criteri <strong>di</strong><br />
valutazione dell' efficacia della terapia nelle spon<strong>di</strong>loartriti<br />
lntemational multicenter validation of <strong>di</strong>agnostic criteri a for psoriatic artbritis (CASPAR):<br />
definizione e validazione dei criteri <strong>di</strong>agnostici per l' artropatia psoriasica<br />
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)<br />
Raccomandazioni EULAR per la terapia della malattia <strong>di</strong> Behçet<br />
Raccomandazioni EULAR per la terapia della vasculiti<br />
EULAR and ACR Diagnostic and Classification criteria in vasculitis<br />
Gruppo multi<strong>di</strong>sciplinare sui farmaci biologici in Reumatologia Regione Emilia Romagna<br />
con definizione <strong>di</strong> registro regionale<br />
3<br />
3
Articoli su riviste con Impact Factor:<br />
1. A.Bellelli, B.Tumiati, C.<strong>Salvarani</strong> et al.: Sindrome <strong>di</strong> Reynolds. Caso clinico e revisione<br />
della letteratura. Analogia con GVHD. Giornale <strong>di</strong> Clinica Me<strong>di</strong>ca, 62:656-64,1981.<br />
2. A.Bellelli, C.Azzarito, C.<strong>Salvarani</strong> et al.:.Sarcoma <strong>di</strong> Kaposi in corso <strong>di</strong> terapia<br />
cortisonica. Descrizione <strong>di</strong> un caso clinico. Giornale <strong>di</strong> Clinica Me<strong>di</strong>ca, 63:6<strong>14</strong>-21,1982.<br />
3. I.Portioli, C.Fantesini, C.<strong>Salvarani</strong> et al.: Morbo <strong>di</strong> Paget del cranio complicato da<br />
demenza idrocefalica: <strong>di</strong>agnosi precoce con la TAC cerebrale e remissione dopo<br />
intervento chirurgico. Me<strong>di</strong>cina, 3:44-6, 1983.<br />
4. C.<strong>Salvarani</strong>, I.Iori, F .Rossi et al.: Neurologic involvement as ftrst sign ofBeh~et's<br />
syndrome. Clin Exp Rheumatol, 2:353-4, 1984.<br />
5. C.<strong>Salvarani</strong>, I.Iori, F .Rossi et al: Hypersensitivity to <strong>di</strong>clofenac with acute hepatitis,<br />
immune-hemolitic anemia, thrombocytopenia and renal involvement. Ital Joumal<br />
Gastroenterol, 16:54-6, 1984.<br />
6. C.<strong>Salvarani</strong>, PL.Macchioni, F .Rossi et al.: Nephrotic syndrome induced by tiopronin:<br />
association with HLA-DR3 antigen. Arthritis Rheum, 28:595-6, 1985.<br />
7. C.<strong>Salvarani</strong>, l.Iori, S.Pran<strong>di</strong> et al: Gold-induced severe apI asti c anemia: medullary<br />
autologous reconstitution after immunosuppression. J Rheumatol, 2:387, 1985.<br />
8. C.<strong>Salvarani</strong>, G.Massai, PL.Macchioni et al: Infarto cerebrale e trombocitopenia in un<br />
caso fatale <strong>di</strong> LES cerebrale: associazione con anticorpi anticar<strong>di</strong>olipina e lupus<br />
anticoagulante. Me<strong>di</strong>cina, 5:426-7, 1985.<br />
9. C.<strong>Salvarani</strong>, PL.Macchioni, F .Rossi et al.: HLA typing, platelet associated<br />
immunoglobulins and anticar<strong>di</strong>olipin antibo<strong>di</strong>es. J Rheumatol, 5:988-90, 1986.<br />
10. C.<strong>Salvarani</strong>, G.Massai, PL.Macchioni et al.: Anticar<strong>di</strong>olipin antibo<strong>di</strong>es in a case<br />
ofNeuro-Behçet with superior vena cavaI occlusion. Clin Rheumatol, 1:88-91, 1987.<br />
11. C.<strong>Salvarani</strong>, PL.Macchioni, PL. Tartoni et al.: Polymyalgia rheumatica and giant celI<br />
arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp<br />
Rheumatol, 5:205-15, 1987.<br />
12. C.<strong>Salvarani</strong>, PL.Macchioni, F.Rossi et al.: Synovitis in polymyalgia rheumatica: a 5year<br />
followup study in Reggio Emilia, Italy. J Rheumatol, <strong>14</strong>:1209-10, 1987.<br />
13. C.<strong>Salvarani</strong>, PL.Macchioni, F.Rossi et al.: Arterite giganto-cellulare: uno stu<strong>di</strong>o<br />
epidemiologico, clinico e patologico durante un periodo <strong>di</strong> 5 anni in Reggio Emilia.<br />
Reumatismo, 40:113-6, 1988.<br />
<strong>14</strong>. C.<strong>Salvarani</strong>, L.Ghirelli, C. Di Lecce et al.: Differenti quadri capillaroscopici, clinici ed<br />
anticorpali nei pazienti con fenomeno <strong>di</strong> Raynaud. Reumatismo, 40:183-6,1988.<br />
4<br />
4
15. C.<strong>Salvarani</strong>, N.Marcello, PL.Macchioni et al.: Hypothyroi<strong>di</strong>sm simulating polymyositis.<br />
Scand J Rheumatol, 17:<strong>14</strong>7-9, 1988.<br />
16. C.<strong>Salvarani</strong>, PL.Macchioni, F .Zizzi et al.: Clinical subgroups and HLA antigens in<br />
Italian patients with psoriatic arthritis. Clin Exp Rheumatol, 7:391-6, 1989.<br />
5<br />
17. C.<strong>Salvarani</strong>, N.Capozzoli, R.Baricchi et al.: Autoimmune <strong>di</strong>sease in hairy-cellleukemia:<br />
systemic vasculitis and anticar<strong>di</strong>olipin syndrome. Clin Exp Rheumatol, 7:329-30,1989.<br />
18. C.<strong>Salvarani</strong>, F .Zizzi, PL.Macchioni et al.: Clinical response to auranofm in patients<br />
with psoriatic arthritis. Clin Rheumatol, 8:54-7,1989.<br />
19. C.<strong>Salvarani</strong>, F.Rossi, PL.Macchioni et al.: Bartter's syndrome and chondrocalcinosis: a<br />
possible role far hypomagnesemia in the deposition of calcium pyrophosphate <strong>di</strong>hydrate<br />
(CPPD) crystals. Clin Exp Rheumatol, 7:415-20,1989.<br />
20. P.Sottilotta, C.<strong>Salvarani</strong>, M.Veneziani et al.: Aspetti psicosociali a <strong>di</strong>sabilità al lavoro<br />
nell'artrite reumatoide: stu<strong>di</strong>o su un campione <strong>di</strong> pazienti della provincia <strong>di</strong> Reggio Emilia.<br />
Reumatismo, 42:192-5, 1990.<br />
21. C.<strong>Salvarani</strong>, PL.Macchioni, F.Zizzi et al.: Low incidence ofproteinuria in RA after gold<br />
thiosulfate treatment. JRheumatol., 17:271-2, 1990.<br />
22. C.<strong>Salvarani</strong>, PL.Macchioni, M. Veneziani et al: Upper limb lymphedema in psoriatic<br />
arthritis. J Rheumatol., 17:273-4, 1990.<br />
23. C.<strong>Salvarani</strong>, F .Zizzi, PL.Macchioni, et al.: Uno stu<strong>di</strong>o clinico dell'artrite reumatoide<br />
dell'anziano. Confronto con un gruppo <strong>di</strong> pazienti con malattia insorta prima dei 60 anni. Il<br />
Reumatologo, 3:107-112;1990.<br />
24. C.<strong>Salvarani</strong>, PL.Macchioni, F.Zizzi et al.: Reply to: Low incidence oftoxicity from gold<br />
thiomalate in Hong Kong chinese patients with rheumatoid arthritis. J Rheumatol, 18:630-<br />
32, 1991.<br />
25. C.<strong>Salvarani</strong>, B.Casali, D.Salvo et al.: The role of interleukin 1, erythropoietin and red<br />
cells bound immunoglobulins in the anaemia ofrheumatoid arthritis. Clin. Exp. Rheumatol.,<br />
9:241-246,1991.<br />
26. C.<strong>Salvarani</strong>, PL.Macchioni, L.Lo<strong>di</strong> et al.: Sjogren's syndrome in human<br />
immunodeficiency virus (HIV) infection: association with HLA-DR3 and CD8 lymphocytosis<br />
in an ltalian patient. Clin. Exp. Rheumatol., 9:437-438, 1991.<br />
27. C.<strong>Salvarani</strong>, D.Lasagni, B.Casali et al.: Recombinant human erythropoietin therapy in<br />
patients with rheumatoid arthritis with the anemia of chronic <strong>di</strong>sease. J Rheumatol18:<br />
1168-71; 1991.<br />
28. C.<strong>Salvarani</strong>, PL.Macchioni, F .Zizzi, et al.: Epidemiologic and immunogenetic aspects<br />
of polymyalgia rheumatica and giant celI arteritis in Northem ltaly. Arthritis Rheum, 34:351-<br />
5
356; 1991.<br />
29. R.Baricchi, R.Carbognani, L.Vecchia, C.<strong>Salvarani</strong>, et al.:Determinazione degli<br />
isoenzimi della fosfatasi alcalina<br />
me<strong>di</strong>ante elettroforesi su gel <strong>di</strong> agarosio in 13 pazienti affetti da sindrome <strong>di</strong> Sjogren<br />
primitiva. Notiziario Clinico, 4: 17- 19; 1991.<br />
6<br />
30. C.<strong>Salvarani</strong>, PL.Macchioni, T.Cremonesi et al.: The cervical spine in psoriatic arthritis:<br />
a clinical, ra<strong>di</strong>ological and immunogenetic study. Ann. Rheum. Dis., 51:73-77,1992.<br />
31. C.<strong>Salvarani</strong>, PL.Macchioni, L.Boiar<strong>di</strong> et al.: Low dose cyclosporine A in psoriatic<br />
arthritis: relation between soluble interleukin 2 receptors and response to therapy. J<br />
Rheumatol, 19:74-79,1992.<br />
32. L.Boiar<strong>di</strong>, C.<strong>Salvarani</strong>, PL.Macchioni, et al.: Immunologic effects in patients with<br />
psoriatic arthritis treated with cyclosporine A. J Rheumatol, 19:1933-37; 1992.<br />
33. C.<strong>Salvarani</strong>, R.Baricchi, PL.Macchioni, et al.: Anticar<strong>di</strong>olipin antibo<strong>di</strong>es in Northem<br />
ltalian population with PMR/GCA. Aro J Med, 92:712-713; 1992.<br />
34. R.Baricchi, L.Boiar<strong>di</strong>, C.<strong>Salvarani</strong>, et al.: Anticorpi anticar<strong>di</strong>olipina e ischemia<br />
miocar<strong>di</strong>ca. Il Patologo Clinico, 7:6<strong>14</strong>-617; 1992.<br />
35. C.<strong>Salvarani</strong>, PL.Macchioni, L.Boiar<strong>di</strong>, et al.: Soluble interleukin 2 receptors in<br />
polymyalgia rheumatica/giant celI arteritis. Clinical and Laboratory correlations. J<br />
RheumatoI19:1100-1106; 1992.<br />
36. C.<strong>Salvarani</strong>, PL.Macchioni, W.Mantovani et al.: Extraarticular manifestations of<br />
rheumatoid arthritis and HLA antigens in Northem ltaly. J Rheumatol, 19:242-46, 1992.<br />
37. C.<strong>Salvarani</strong>, F .Rossi, PL.Macchioni et al.: Synovitis in polymyalgia rheumatica: an<br />
immunogenetic study. Brit J Rheumatol, 1:720; 1992.<br />
38. C.<strong>Salvarani</strong>, PL.Macchioni, L.Boiar<strong>di</strong> et al.: Reply to Gonzalez-Gay et al. letter on"<br />
Temporal arteritis in Northwestern Spain". Arthritis Rheum (letter), 35:1250,1992.<br />
39. C.<strong>Salvarani</strong>, PL.Macchioni, W.Mantovani et al.: Polymyalgia rheumatica and<br />
seronegative rheumatoid arthritis: some considerations based on a Northem Italian<br />
population. J Rheumatol, 20:756-57, 1993.<br />
40. C.<strong>Salvarani</strong>, L.Boiar<strong>di</strong>, M.Casadei Mal<strong>di</strong>ni, et al.: High dose immunoglobulin therapy in<br />
a case of inclusion body myositis: clinical and immunologic aspects. J Rheumatol,<br />
20:<strong>14</strong>55-56; 1993.<br />
41. C.<strong>Salvarani</strong>, B.Casali, L.Boiar<strong>di</strong>, et al.: Low molecular weight IgM in primary Sjogren's<br />
syndrome. Clin Exp Rheumatol 639-642,1993.<br />
42. PL.Macchioni, L.Boiar<strong>di</strong>, C.<strong>Salvarani</strong> et al.: Lymphocyte subpopulations analysis in<br />
peripheral blood in polymyalgia rheumatica/giant celI arteritis. Br J Rheumatol, 32:66-670,<br />
6
1993.<br />
43. C. <strong>Salvarani</strong>: L'anemia nell'artrite reumatoide. Il Reumatologo, <strong>14</strong>:229-231; 1993.<br />
7<br />
44. L.Boiar<strong>di</strong>, P .Macchioni, C.<strong>Salvarani</strong>, et al.: Se rum soluble interleukin-2 receptor<br />
levels in rheumatoid arthritis: corre la ti o n with clinical and immunological parameters and<br />
with the response to auranofm treatment. Clin Exp Rheumatol, 12:357-362, 1994.<br />
45. C.<strong>Salvarani</strong>, L.Boiar<strong>di</strong>, PL.Macchioni, et al.: Serum soluble CD4 and CD8 levels in<br />
polymyalgia rheumatica. JRheumatol, 21:1865-69,1994.<br />
46. PL.Macchioni, L.Boiar<strong>di</strong>, R.Meliconi, C.<strong>Salvarani</strong>, et al.: Elevated soluble intercellular<br />
adhesion mole cuI e 1 in the serum of patients with polymyalgia rheumatica: influence of<br />
steroid treatment. J Rheumatol, 21: 1860-64; 1994.<br />
47. C.<strong>Salvarani</strong>, SE Gabriel, MA Gertz et al.: Primary systemic amyloidosis presenting as<br />
giant celI arteritis and polymyalgia rheumatica. Arthritis Rheum, 37:1621-26, 1994.<br />
48. P.Nurchis, C.<strong>Salvarani</strong>, F.Zizzi et al.: Rheumatoid arthritis in the elderly: frequency<br />
ofside effects ofparenteral and oral chrysotherapy. Eur J Int Med, 5:27-32, 1994.<br />
49. C.<strong>Salvarani</strong>, SE Gabriel, WM O'FalIon, GG Hunder: Epidemiolgy ofpolymyalgia<br />
rheumatica in OIrosted County, Minnesota, 1970-1991. Arthritis Rheum, 38:369-73,1995.<br />
50. C.<strong>Salvarani</strong>: Upper limb lymphedema in inflammatory arthropathy. J Rheumatol,<br />
22:370, 1995.<br />
51. C.<strong>Salvarani</strong>, L.Boiar<strong>di</strong>, PL.Macchioni et al.: On the utility of CD8 levels assessment in<br />
the <strong>di</strong>agnosis of polymyalgia rheumatica/giant celI arteritis. Clin Exp Rheumatol, 13:129-<br />
30, 1995.<br />
52. C.<strong>Salvarani</strong>, L.Boiar<strong>di</strong>, PL.Macchioni, et al.: The role ofperipheral CD8+ lymphocytes<br />
and soluble IL-2 receptor in pre<strong>di</strong>cting the duration of corticosteroid treatment in<br />
polymyalgia rheumatica and giant celI arteritis, Ann Rheum Dis, 54:640-44,1995.<br />
53. C.<strong>Salvarani</strong>, SE Gabriel, WM O'Fallon, GG Hunder: The incidence of giant celI arteritis<br />
in OIrosted County, Minnesota, apparent fluctuations in a cyclic pattem. Ann Intem Med,<br />
123:192-194, 1995.<br />
54. <strong>Salvarani</strong>, G. Lo Scocco, PL. Macchioni, et al.: Prevalence ofpsoriatic arthritis in Italian<br />
psoriatic patients. J Rheumatol, 12:<strong>14</strong>99-1503, 1995.<br />
55. C.<strong>Salvarani</strong>, R.Baricchi, D.Lasagni et al.: Chronic <strong>di</strong>sease anemia associated with<br />
rheumatoid arthritis: effects of desferrioxamine therapy on anemia and clinical status.<br />
Rheumatology Intemational, 16:45-48, 1996.<br />
56. R. Meliconi, C.<strong>Salvarani</strong>, PL. Macchioni, et al.: Leucocyte infiltration in synovial tissue<br />
from the shoulder of patients with polymyalgia rheumatica. Arthritis Rheum, 39:1199-1206,<br />
1996.<br />
7
57. C.<strong>Salvarani</strong>, S.Gabriel, GG.Hunder: Reply. Giant cell arteritis and amyloidosis:<br />
comment on the article by <strong>Salvarani</strong> et al. Arthritis Rheum, 39:1073, 1996.<br />
8<br />
58. L.Boiar<strong>di</strong>, C.<strong>Salvarani</strong>, PL.Macchioni et al.: CD8 lymphocyte subsets in active<br />
polymyalgia rheumatica: comparison with elderly-onset and adult rheumatoid arthritis and<br />
influence of prednisone therapy. Br J Rheumatol, 35:642-48, 1996.<br />
59. C.<strong>Salvarani</strong>, L.Boiar<strong>di</strong>, PL.Macchioni et al.: Polymyalgia rheumatica. Lancet, 348:550-<br />
551,1996.<br />
60. C.<strong>Salvarani</strong>, S.Gabriel, GG.Hunder: DistaI extremity swelling with pitting edema in<br />
polymyalgia rheumatica. Report ofnineteen cases. Arthritis Rheum, 3'9:73-80,1996.<br />
61. C.<strong>Salvarani</strong>, S.Gabriel, GG.Hunder: Reply. Il Comparison of polymyalgia rheumatica<br />
and remitting seronegative symmetrical synovitis with pitting edema syndrome: comment<br />
on the article by <strong>Salvarani</strong> et al. Arthritis Rheum, 39:1931-1932,1996.<br />
62. C. <strong>Salvarani</strong>, I. Olivieri, F .Cantini, L.Barozzi: E' la sindrome "RS3PE" una entità<br />
autonoma. Reumatismo, 48:201-204, 1996.<br />
63. M.Massari, C.<strong>Salvarani</strong>, I.Portioli, et al.: Polyarteritis nodosa and mv infection: no<br />
evidence of a <strong>di</strong>rect pathogenic role of HIV. Infection, 24:159-61,1996.<br />
64. I.Olivieri, C.<strong>Salvarani</strong>, F.Cantini: Remitting <strong>di</strong>staI extremity swelIing with pitting edema:<br />
a <strong>di</strong>stinct syndrome or a clinical feature of <strong>di</strong>fferent inflammatory rheumatic <strong>di</strong>seases? J<br />
Rheumatol, 24:249-52; 1997.<br />
65. C.<strong>Salvarani</strong>, F .Cantini, I.Olivieri et al.: Isolated peripheral enthesitis andlor dactylitis: a<br />
subset of psoriatic arthritis. J Rheumatol, 24:1106-10; 1997.<br />
66. C.<strong>Salvarani</strong>, F.Cantini, I.Olivieri et al.: Proximal bursitis in active polymyalgia<br />
rheumatica. Ann Intem Med, 127:27-31, 1997.<br />
67. C.<strong>Salvarani</strong>, PL Macchioni, L.Boiar<strong>di</strong>: Polymyalgia rheumatica. Lancet, 350:43-47,<br />
1997.<br />
68. F.Cantini, L.Emmi, C.<strong>Salvarani</strong>, et al.: Lack of association between chronic hepatitis c<br />
virus infection and Behçet's <strong>di</strong>sease. Clio Exp Rheumatol, 15:338-339, 1997.<br />
69. SE Gabriel, J Sunku, C.<strong>Salvarani</strong> et al.: Long-term outcome of anti-inflammatory<br />
therapy among patients with polymyalgia rheumatica. Arthritis Rheum, 40: 1873-8, 1997.<br />
70. R.Meliconi, L.PulsatelIi, C.<strong>Salvarani</strong>, et al.: Synovial expression of celI adhesion<br />
molecules in polymyalgia rheumatica. ClinExplmmunol; 107:494-500, 1997.<br />
71. I.Olivieri, F.Cantini, C.<strong>Salvarani</strong>: Diagnostic and classification criteria for<br />
spondyloarthropathies, clinical and functional assessment, and therapeutic advances. Curr<br />
Opin Rheumatol; 9:284-90, 1997.<br />
8
9<br />
72. I.Olivieri, C.<strong>Salvarani</strong>, F. Cantini, et al.: Therapy with cyclosporine in psoriatic arthritis.<br />
Semin Arthritis Rheum ; 27:36-43, 1997.<br />
73. I.Olivieri, C.<strong>Salvarani</strong>, F .Cantini: Is Behçet's <strong>di</strong>sease part of spondyloarthritis<br />
complex? J Rheumatol; 24:1870-2, 1997.<br />
74. F.Cantini, L.Niccoli, C.<strong>Salvarani</strong>, et al.: Remitting <strong>di</strong>staIlower extremity swelIing with<br />
pitting oedema in acute sarcoidosis. Ann Rheum Dis; 56:565-6, 1997.<br />
75. I.Olivieri, C.<strong>Salvarani</strong>, F .Cantini et al.: DistaI extremity swelIing with pitting edema in<br />
polymyalgia rheumatica: a case stu<strong>di</strong>ed with MRI. Clin Exp Rheumatol; 15:710-1, 1997.<br />
76. C.<strong>Salvarani</strong>, PL.Macchioni, W.Mantovani et al.: HLA-DRBI alleles associated with<br />
rheumatoid arthritis in Northem ltaly. Correlation with <strong>di</strong>sease severity. British J<br />
Rheumatol; 37:165-9, 1998.<br />
77. F .Cantini, I.Olivieri, C.<strong>Salvarani</strong>: More on remitting seronegative symmetrical synovitis<br />
with pitting edema as a paraneoplastic syndrome: J Rheumatol; 25:188-9,1998.<br />
78. P .Macchioni, L.Boiar<strong>di</strong>, C.<strong>Salvarani</strong>, et al.: Serum chemokines in patients with<br />
psoriatic arthritis treated with cyclosporin A. J Rheumatol; 25:320-5, 1998.<br />
79. F .Cantini, C.<strong>Salvarani</strong>, I.Olivieri et al.: Possible association between eosinophilic<br />
fasciitis and subcutaneous heparin use. J Rheumatol; 25:383-5, 1998.<br />
80. A.Padula, C.<strong>Salvarani</strong>, L.Barozzi, et al: Dactylitis also involving the synovial sheaths in<br />
the palm ofthe hand: two more cases stu<strong>di</strong>ed by magnetic resonance imaging. Ann<br />
Rheum Dis; 57:61-2,1998.<br />
81. F .Cantini, C.<strong>Salvarani</strong>, I.Olivieri: Erythrocyte se<strong>di</strong>mentation rate and C-reactive<br />
protein in the <strong>di</strong>agnosis of polymyalgia rheumatica. Ann Intern Med; 128:873-4, 1998.<br />
82. L.Pulsatelli, R.Meliconi, C.<strong>Salvarani</strong>, et al.: Elevated serum concentrations of the<br />
chemokine RANTES in patients with polymyalgia rheumatica. Clin Exp Rheumatol;<br />
16:263-8, 1998.<br />
83. F .Cantini, C.<strong>Salvarani</strong>, I.Olivieri, et al.: Tuberculous spondylitis as a cause of<br />
inflammatory spinal pain: a report of 4 cases. Clin Exp Rheumatol; 16:305-8, 1998.<br />
84. C.<strong>Salvarani</strong>, F .Cantini, P .Macchioni, et al.: DistaI musculoskeletal manifestations in<br />
polymyalgia rheumatica: a prospective followup study. Arthritis Rheum; 41:1221-6, 1998.<br />
85. P .Macchioni, L.Boiar<strong>di</strong>, C.<strong>Salvarani</strong>, et al.: The relationship between serum-soluble<br />
interleukin-2 receptor and ra<strong>di</strong>ological evolution in psoriatic arthritis patients treated with<br />
cyclosporin-A. Rheumatol Int; 18:27-33, 1998.<br />
86. I.Olivieri, L.Barozzi, C.<strong>Salvarani</strong>, et al.: Retrocalcaneal bursitis in spondyloarthropathy:<br />
assessment by ultrasonography and magnetic resonance imaging. J Rheumatol; 25:1352-<br />
7,1998.<br />
9
87. C.<strong>Salvarani</strong>, I.Olivieri, F.Cantini, et al.: Psoriatic arthritis. Curr Opin Rheumatol;<br />
10:299-305, 1998.<br />
88. F .Cantini, C.<strong>Salvarani</strong>, L.Niccoli, et al.: Behçet's <strong>di</strong>sease with unusual cutaneous<br />
lesions. J Rheumatol; 25:2469-72, 1998.<br />
89. C.<strong>Salvarani</strong>, I.Olivieri, F.Cantini, GG. Hunder: Classification ofinflammatory arthritis.<br />
Lancet; 352:1938,1998.<br />
10<br />
90. <strong>Salvarani</strong> C, Macchioni L, Olivieri I, Cantini F, Boiar<strong>di</strong> L. Diagnosis and management<br />
of polymyalgia rheumatica/giant cell arteritis. BioDrugs. 1998; 9:25-32.<br />
91. A.Padula, F .Belsito, C.<strong>Salvarani</strong>, et al.: Isolated tenosynovitis associated with<br />
psoriasis triggered by physical injury. Clin Exp Rheumatol;<br />
17:103-4, 1999.<br />
92. C.<strong>Salvarani</strong>, F .Cantini, I. Olivieri, GG. Hunder: Polymyalgia rheumatica: a <strong>di</strong>sorder of<br />
extraarticular synovial structures. J Rheumatol; 26:517-21,1999.<br />
93. C.<strong>Salvarani</strong>, L.Boiar<strong>di</strong>, V.Mantovani, et al.: HLA-DRBI alleles associated with<br />
polymyalgia rheumatica in northem ltaly: correlation with <strong>di</strong>sease severity. Ann Rheum<br />
Dis; 58:303-8, 1999.<br />
94. F.Cantini, C.<strong>Salvarani</strong>, I.Olivieri, et al.: Remitting seronegative symmetrical synovitis<br />
with pitting oedema (RS3PE) syndrome: a prospective follow-up and magnetic resonance<br />
imaging study. Ann Rheum Dis; 58:230-6,1999.<br />
95. C.<strong>Salvarani</strong>, GG.Hunder: Musculoskeletal manifestations in a population-based cohort<br />
ofpatients with giant celI arteritis. Arthritis Rheum; 42:1259-66, 1999.<br />
96. MA. Gonzalez-Gay, C. Garcia-Porrua, C.<strong>Salvarani</strong>, GG. Hunder: Diagnostic approach<br />
in a patient presenting with polymyalgia. Clin Exp Rheumatol; 17:276-8, 1999.<br />
97. F.Cantini, C.<strong>Salvarani</strong>, L.Niccoli, et al: Treatment of thrombophlebitis of Behçet's<br />
<strong>di</strong>sease with low dose cyclosporin A. Clin Exp Rheumatol; 17:391-2, 1999.<br />
98. C.<strong>Salvarani</strong>, F .Cantini, I.Olivieri, et al.: Distal extremity swelling with pitting edema in<br />
psoriatic arthritis: evidence of 2 pathological mechanisms. J Rheumatol; 26:1831-4,1999.<br />
99. L.Boiar<strong>di</strong>, P .Macchioni, C.<strong>Salvarani</strong>, et al.: Relationship between serum RANTES<br />
levels and ra<strong>di</strong>ological progression in rheumatoid arthritis patients treated with<br />
methotrexate. Clin Exp Rheumatol; 17:419-25, 1999.<br />
100. F .Cantini, C.<strong>Salvarani</strong>, I.Olivieri, et al.: Hip bursitis in active polymyalgia rheumatica:<br />
report of a case. Clin Exp Rheumatol; 17:512-3, 1999.<br />
101. A.Padula, L.Barozzi, C.<strong>Salvarani</strong>, et al: Involvement oftransitionallumbosacraljoints in<br />
10
11<br />
spondyloarthritis. Clin Exp Rheumatol; 17:636-7, 1999.<br />
102. C.<strong>Salvarani</strong>, L.Boiar<strong>di</strong>, V.Mantovani, et al.: HLA-DRBl, DQAl and DQBl alleles<br />
associated with giant celI arteritis in northem Italy. J Rheumatol; 26:2395-9,1999.<br />
103. F.Cantini, C.<strong>Salvarani</strong>, I.Olivieri: Shoulder sonographic fm<strong>di</strong>ngs in polymyalgia<br />
rheumatica. J Rheumatol; 26:2501-2, 1999.<br />
104. F .Cantini, C.<strong>Salvarani</strong>, I.Olivieri: Paraneoplastic remitting seronegative symmetrical<br />
synovitis with pitting edema. Clin ExpRheumatol; 17: 741-4,1999.<br />
105. C.<strong>Salvarani</strong>, K.Calamia, M.Silingar<strong>di</strong>, et al.: Thrombosis associated with the<br />
prothrombin G-A20210 mutation in Behçet's <strong>di</strong>sease. J Rheumatol; 27:515-6, 2000<br />
106. C. <strong>Salvarani</strong>, B. Casali, L.Boiar<strong>di</strong>, et al.: Intercellular adhesion molecule 1 gene<br />
polymorphisms in polymyalgia rheumatica/giant celI arteritis: association with <strong>di</strong>sease risk<br />
and severity. J Rheumatol; 27:1215-21, 2000.<br />
107. C. <strong>Salvarani</strong>, F.Cantini, I. Olivieri, et al.: Corticosteroid injections in polymyalgia<br />
rheumatica: a double-blind prospective, randomized, placebo-controlled study. J<br />
Rheumatol ; 27: <strong>14</strong>70-6,2000.<br />
108. MA. Gonzalez-Gay, C. Garcia-Porrua, C.<strong>Salvarani</strong>, GG. Hunder: Cutaneous<br />
vasculitis and cancer: a clinical approach. Clin Exp Rheumatol; 18:305-7, 2000.<br />
109. M.Schirmer, KT. Calamia, C.<strong>Salvarani</strong>: First Intemational conference on polymyalgia<br />
rheumatica and giant celI arteritis, Prato, Italy. May 25-26,1999. J Rheumatol; 27:1801-3,<br />
2000.<br />
110. P. Pavlica, L. Barozzi, C. <strong>Salvarani</strong>, et al: Magnetic resonance imaging in the<br />
<strong>di</strong>agnosis of PMR. Clin Exp Rheumatol; 18:S38-9,2000.<br />
111. C. <strong>Salvarani</strong>, F .Cantini, I.Olivieri: DistaI musculoskeletal manifestations in<br />
polymyalgia rheumatica. Clin Exp Rheumatol; 18:S51-2, 2000.<br />
112. I. Olivieri, C. <strong>Salvarani</strong>, F.Cantini: RS3PE syndrome: an overview. Clin Exp<br />
Rheumatol; 18:S53-5, 2000.<br />
113. F. Cantini, C. <strong>Salvarani</strong>, I. Olivieri, et al: Erythrocyte se<strong>di</strong>mentation rate and Creactive<br />
protein in the evaluation of <strong>di</strong>sease activity and severity in polymyalgia<br />
rheumatica: a prospective follow-up study. Semin Arthritis Rheum;30: 17-24, 2000.<br />
1<strong>14</strong>. MA. Gonzalez-Gay, C. Garcia-Porrua, C. <strong>Salvarani</strong>, et al: The spectrum of con<strong>di</strong>tions<br />
mimicking polymyalgia rheumatica in Northwestem Spain. J Rheumatol; 27:2179-84,<br />
2000.<br />
115. C. <strong>Salvarani</strong>, G. Fomaciari, M. Beltrami, et al: Musculoskeletal manifestations in<br />
inflammatory bowel <strong>di</strong>sease. Eur J Int Med; 210-<strong>14</strong>; 2000.<br />
11
12<br />
116. Cimmino MA., <strong>Salvarani</strong> C., Macchioni P., et al: Extra-articular manifestations in 587<br />
Italian patients with rheumatoid arthritis. Rheumatol lnt; 19:213-7,2000.<br />
117. Macchioni P., Boiar<strong>di</strong> L., <strong>Salvarani</strong> C., et al : Intercellular adhesion molecu1es 1<br />
(ICAM-I) gene polymorphisms in Italian patients with rheumatoid arthritis. Clin Exp<br />
Rheumatol ; 18 :553-8,2000.<br />
118. <strong>Salvarani</strong> C., Boiar<strong>di</strong> T., Timms JM., et al : Absence of the association with CC<br />
chemokine receptor 5 polymorphism in polymyalgia rheumatica. Clin Exp Rheumatol; 18<br />
:591-5,2000.<br />
119. Me1iconi R., Pu1satelli L., Sa1varani C., et al: Vascu1ar endothe1ia1 growth factor<br />
production in po1ymyalgia rheumatica. Arthritis Rheum ; 43 :2472-80,2000.<br />
120. Boiar<strong>di</strong> L., <strong>Salvarani</strong> C., Timms JM., et al: Inter1eukin-1 c1uster and tumor necrosis<br />
factor-a1pha gene po1ymorphisms in polymya1gia rheumatica. C1in Exp Rheumatol ; 18<br />
:675-81,2000.<br />
121. Gonzalez-Gay MA., Garcia-Porrua C., <strong>Salvarani</strong> C., et al : Polymya1gia<br />
manifestations in <strong>di</strong>fferent con<strong>di</strong>tions mimicking po1ymya1gia rheumatica. C1in Exp<br />
Rheumato1; 18 :755-9,2000.<br />
122. <strong>Salvarani</strong> C., Hunder GG. : Giant cell arteritis with low erythrocyte se<strong>di</strong>mentation rate:<br />
frequency of occurrence in a population-based study. Arthritis Rheum; 45 :<strong>14</strong>0-5,2001.<br />
123. Cantini F., <strong>Salvarani</strong> C., Olivieri I., et al : Inflamed shou1der structures in<br />
po1ymyalgia rheumatica with normal erythrocyte se<strong>di</strong>mentation rate. Arthritis Rheum ; 44 :<br />
1155-9, 2001.<br />
124. Cantini F., <strong>Salvarani</strong> C., Olivi eri I., et al : Shou1der u1trasonography in the <strong>di</strong>agnosis<br />
of polymya1gia rheumatica : a case contro1 study. J Rheumato1; 28 :1049-55,2001.<br />
125. Cantini F., <strong>Salvarani</strong> C., 01ivieri I., et al : Distai extremity swelling with pitting edema<br />
in psoriatic arthritis: a case- contro1 study. Clin Exp Rheumato1 ; 19 :291-6,2001.<br />
126. Boiar<strong>di</strong> L., <strong>Salvarani</strong> C., Casali B., et al: Intercellular adhesion molecule-1 gene<br />
po1ymorphisms in Behcet's <strong>di</strong>sease. J Rheumato1; 28 :1283-7,2001.<br />
127. Fomaciari G., <strong>Salvarani</strong> C., Be1trami M., et al : Musco1oske1eta1 manifestations in<br />
inflammatory bowe1 <strong>di</strong>sease. Can J Gastroentero1; 15 :399-403,2001.<br />
128. Gonzalez-Gay MA., Garcia-Porrua C., Pujo1 RM., <strong>Salvarani</strong> C. : Erythema nodosum<br />
: a clinica1 approach. C1in Exp Rheumato1; 19 :365-8,2001.<br />
129. <strong>Salvarani</strong> C., Boiar<strong>di</strong> L., Mantovani V., et al: Association of MICA alleles and HLA-<br />
B51 in Italian patients with Behcet's <strong>di</strong>sease. JRheumato1; 28 :1867-70,2001.<br />
130. Olivieri I., <strong>Salvarani</strong> C., Cantini F., et al: Anky1osing spondy1itis and un<strong>di</strong>fferentiated<br />
spondy1oarthropathies : a c1inica1 review and description of a <strong>di</strong>sease subset with older<br />
12
13<br />
age at onset. Curr Opin Rheumatol ; 13 :280-4,2001.<br />
131. <strong>Salvarani</strong> C., Macchioni P., 01ivieri I., et al : A comparison of cyc1osporine,<br />
sulfasalazine, and symptomatic therapy in the treatment ofpsoriatic arthritis. J Rheumato1;<br />
28 :2274-82,2001.<br />
132. Ghirarduzzi A., Galimberti D., <strong>Salvarani</strong> C., et al: Left atrial thrombosis in patients<br />
with antiphospho1ipid antibody syndrome and mesenchyma1 abnormal septum. Ita1 Heart<br />
Supp1 ; 2 : 1111-6, 200 l.<br />
133. 01ivieri I., Padu1a A., <strong>Salvarani</strong> C., et al: Retroca1canea1 bursitis in po1ymya1gia<br />
rheumatica. Ann Rheum Dis ; 60:1160- l, 200 l.<br />
134. <strong>Salvarani</strong> C., Vlachonikolis IG., van der Heijde DM., et al : Muscu1oskeleta1<br />
manifestations in a popu1ation-based cohort of inflammatory bowel <strong>di</strong>sease patients.<br />
Scand J Gastroenterol ; 36 : 1307-13, 200 l.<br />
135. Cantini F., Nicco1i L., <strong>Salvarani</strong> C., et al: Treatment oflongstan<strong>di</strong>ng active giant cell<br />
arteritis with infliximab : report of four cases. Arthritis Rheum ; 44 :2933-5,2001.<br />
136. 01ivieri I., Padu1a A., <strong>Salvarani</strong> C., et al: Successfu1 treatment of SAPHO syndrome<br />
with infliximab : report of two cases. Ann Rheum Dis; 61 :375-6,2002.<br />
137. Palazzi C., 01ivieri I., Petricca A., <strong>Salvarani</strong> C. : Rheumatoid arthritis or psoriatic<br />
symmetric po1yarthritis? A <strong>di</strong>fficu1t <strong>di</strong>fferential <strong>di</strong>agnosis. C1in Exp Rheumatol ; 20 :3-4,<br />
2002.<br />
138. <strong>Salvarani</strong> C., Boiar<strong>di</strong> L., Casali B., et al: Endothelial nitric oxide synthase gene<br />
po1ymorphisms in Behcet's <strong>di</strong>sease. J Rheumato1 ; 29 :535-40, 2002.<br />
139. Cutolo M., Straub RH., <strong>Salvarani</strong> C., et al: Adrenal gland hypofunction in active<br />
polymyalgia rheumatica. Effect of glucocorticoid treatment on adrenal hormones and<br />
interleukin-6. J Rheumatol ; 29 :748-56, 2002.<br />
<strong>14</strong>0. Piccoli GB., Quaglia M., <strong>Salvarani</strong> C., et al: Ankylosing spondylitis : a <strong>di</strong>fficult<br />
<strong>di</strong>agnosis in patients on long-tenn renal replacement therapy. J Nephrol ; 15 : 177 -82,<br />
2002.<br />
<strong>14</strong>1. Palazzi C., Olivieri I., <strong>Salvarani</strong> C., et al: Reactive arthritis : advances in <strong>di</strong>agnosis<br />
and treatment. Reumatismo; 54 :105-12, 2002.<br />
<strong>14</strong>2. Niccoli L., <strong>Salvarani</strong> C., Baroncelli G., et al: Renal celI carcinoma mimicking<br />
polymyalgia rheumatica. Clues far a correct <strong>di</strong>agnosis. Scand J Rheumatol; 31 :103-<br />
6,2002.<br />
<strong>14</strong>3. Cutolo M., Sulli A., <strong>Salvarani</strong> C., et al: Cortisol dehydroepiandrosterone sulfate, and<br />
androstene<strong>di</strong>one levels in patients with polymyalgia rheumatica during twelve months of<br />
glucocorticoid therapy. Ann N Y Acad Sci; 966-91 :91, 2002.<br />
13
<strong>14</strong><br />
<strong>14</strong>4. <strong>Salvarani</strong> C., Cantini F., Boiar<strong>di</strong> L., Hunder GG .: Polymyalgia rheumatica and giant<br />
celI arteritis. N Engl J Med ; 347 :261-71,2002.<br />
<strong>14</strong>5. <strong>Salvarani</strong> C., Silingar<strong>di</strong> M., Ghirarduzzi A., et al: Is duplex ultrasonography useful far<br />
the <strong>di</strong>agnosis of giant-cell arteritis? Ann Intern Med; 137 :232-8,2002.<br />
<strong>14</strong>6. Olivieri I., <strong>Salvarani</strong> C., Cantini F., et al : Fast spin echo- T2 weighted sequences with<br />
fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the<br />
flexor <strong>di</strong>gitorum tendons. Arthritis Rheum ; 46 :2964-7, 2002.<br />
<strong>14</strong>7. <strong>Salvarani</strong> C., Fametti E., Casali B., et al: Detection of parvovirus B19 DNA by<br />
polymerase chain reaction in giant cell arteritis :a case-contraI study. Arthritis Rheum ; 46<br />
:3099-101,2002.<br />
<strong>14</strong>8. <strong>Salvarani</strong> C., Cantini F., Olivieri I.: Disease-mo<strong>di</strong>fying antirheumatic drug therapy far<br />
psoriatic arthritis. Clin Exp Rheumatol; 20 :S71-5, 2002.<br />
<strong>14</strong>9. Olivieri I., van Tubergen A., <strong>Salvarani</strong> C., van der Linden S. : Seronegative<br />
spondyloarthritides. Best Pract Res Clin Rheumatol; 16 :723-39,2002.<br />
150. Schirmer M., Calamia KT., <strong>Salvarani</strong> C., et al: 18F-fluorodeoxyglucose-positron<br />
emission tomography: a new explorative perspective. Exp Gerontol ; 38 :463-70, 2003.<br />
151. <strong>Salvarani</strong> C., Cantini F., Niccoli L., et al: Treatment of refractory polymyalgia<br />
rheumatica with infliximab : a pilot study. J Rheumatol; 30 :760-3,2003.<br />
152. Olivieri I., Padula A., <strong>Salvarani</strong> C., et al: Persistent efficacy of tumor necrosis factor<br />
alpha blockage therapy in SAPHO syndrome. Arthritis Rheum; 48 : <strong>14</strong>67,2003.<br />
153. <strong>Salvarani</strong> C., Cantini F., Olivieri I., et al : Efficacy of infliximab in resistant psoriatic<br />
arthritis. Arthritis Rheum ; 49 :541-5,2003.<br />
154. Boiar<strong>di</strong> L., Casali B., <strong>Salvarani</strong> C., et al: Vascular endothelial growth factor gene<br />
polymorphisms in giant celI arteritis. J Rheumatol ; 30 :2160-4,2003.<br />
155. <strong>Salvarani</strong> C., Casali B., Nicoli D., et al: Endothelial nitric oxide synthase gene<br />
polymorphisms in giant celI arteritis. Arthritis Rheum; 48 :3219-23,2003.<br />
156. Cantini F., <strong>Salvarani</strong> C., Niccoli L., et al: Fat suppression magnetic resonance<br />
imaging in shoulders ofpatients with polymyalgia rheumatica. J Rheumatol; 31 :120-<br />
4,2004.<br />
157. Wenger M., Calamia KT., <strong>Salvarani</strong> C., et al: Do we need 18F-FDG-positron<br />
emission tomography as a functional imaging technique far <strong>di</strong>agnosing large vessel<br />
arteritis? Clin Exp Rheumatol ; 21 :SI-2, 2003.<br />
158. <strong>Salvarani</strong> C., Cantini F., Boiar<strong>di</strong> L., Hunder GG. : Laboratory investigations useful in<br />
giant celI arteritis and Takayasu' s arteritis. Clin Exp Rheumatol ; 21 :S23-8, 2003.<br />
<strong>14</strong>
159. Gonzalez-Gay MA., Garcia-Porrua C., <strong>Salvarani</strong> C., et al. Cutaneous vasculitis : a<br />
<strong>di</strong>agnostic approach. Clin Exp Rheumatol; 21 :S85-8, 2003.<br />
160. <strong>Salvarani</strong> C. : Large vessel vasculitis. Clin Exp Rheumatol ; 21 :SI33-4, 2003.<br />
161. Olivieri I., <strong>Salvarani</strong> C., Cantini F., et al : Recommendations for starting anti- TNFalpha<br />
in patients with ankylosing spondylitis. Reumatismo; 55 :220-3,2003.<br />
15<br />
162. Gonzalez-Gay MA., Boiar<strong>di</strong> L., Salvar'ani C., et al: Geographical and genetic factors<br />
do not account for significant <strong>di</strong>fferences in the clinical spectrum of giant cell arteritis in<br />
southern Europe. J Rheumatol ; 31 :520-3, 2004.<br />
163. Silingar<strong>di</strong> M., <strong>Salvarani</strong> C., Boiar<strong>di</strong> L., et al: Factor VI Leiden and prothrombin gene<br />
G20210A mutations in Italian patients with Behcet's <strong>di</strong>sease and deep vein thrombosis.<br />
Arthritis Rheum; 51 :177-83,2004.<br />
164. <strong>Salvarani</strong> C., Crowson CS., O'Fallon WM., et al: Reappraisal of the epidemiology of<br />
giant celI arteritis in Olmsted County, Minnesota over a fifty-year period Arthritis Rheum ;<br />
51 :264-8, 2004.<br />
165. Cantini F., Niccoli L., <strong>Salvarani</strong> C., et al: Are polymyalgia rheumatica and giant celI<br />
arteritis the same <strong>di</strong>sease ? Semin Arthritis Rheum ; 33 :294-301,2004.<br />
166. Pulsatelli L., Dolzani P., Salvar ani C., et al. Soluble receptor activator of nuclear<br />
factor-kappaB Ligand (sRANK)/osteoprotogerin balance in ageing and age-associated<br />
<strong>di</strong>seases. Biogerontology ; 5 : 119-27,2004.<br />
167. Cimmino MA, Macchioni P, <strong>Salvarani</strong> C, et al : Pulse steroid treatment of polymyalgia<br />
rheumatica. Clin Exp Rheumatol; 22 :381-2,2004.<br />
168. <strong>Salvarani</strong> C, Boiar<strong>di</strong> L, Casali B, Olivieri I, Cantini F, Salvi F, Malatesta R, La Corte<br />
R, Triolo G, Ferrante A, Filippini D, Paolazzi G, Sarzi-Puttini P, Nicoli D, Farnetti E, Chen<br />
Q, Pulsatelli L. Vascular endothelial growth factor gene polymorphisms in Behcet's<br />
<strong>di</strong>sease.J Rheumatol. 2004; 31:1785-9.<br />
169. <strong>Salvarani</strong> C, Olivieri I, Cantini F, Marchesoni A, Punzi L, Scarpa R, Matucci-Cerinic<br />
M. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with<br />
psoriatic arthritis. Italian Rheumatology Society.] Reumatismo. 2004; 56:133-4<br />
170. Pipitone N, Boiar<strong>di</strong> L, Olivieri I, Cantini F, Salvi F, Malatesta R, La Corte R, Triolo G,<br />
Ferrante A, Filippini D, Paolazzi G, Sarzi-Puttini P, Restuccia G, <strong>Salvarani</strong> C. Clinical<br />
manifestations of Behcet's <strong>di</strong>sease in 137 Italian patients: results of a multicenter<br />
study.Clin Exp Rheumatol. 2004;22 ( Suppl 36):S46-51.<br />
171. Silingar<strong>di</strong> M, Iotti M, Trenti C, <strong>Salvarani</strong> C, Iori I. Thalidomide, deep venous<br />
thrombosis and vasculitis. J Thromb Haemost. 2004;2:2062-3.<br />
172. Klauser A, Bollow M, Calin A, Frauscher F, Kainberger F, Moncayo R, <strong>Salvarani</strong> C,<br />
Sieper J, zur Nedden D, Schirmer M. Workshop report: clinical <strong>di</strong>agnosis and imaging of<br />
sacroiliitis, Innsbruck, Austria, October 9, 2003. J Rheumatol. 2004;31:2041-7.<br />
15
16<br />
173. Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, <strong>Salvarani</strong> C, Montecucco<br />
C; Systemic Vasculitis Study Group of the Italian Society for Rheumatology. Prednisone<br />
plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebocontrolled<br />
trial. Ann Intern Med. 2004;<strong>14</strong>1:493-500.<br />
174. <strong>Salvarani</strong> C, Cantini F, Boiar<strong>di</strong> L, Hunder GG. Polymyalgia rheumatica. Best Pract<br />
Res Clin Rheumatol. 2004;18:705-22.<br />
175. Calin A, Dijkmans BA, Emery P, Hakala M, Kalden J, Leirisalo-Repo M, Mola EM,<br />
<strong>Salvarani</strong> C, Sanmarti R, Sany J, Sibilia J, Sieper J, van der Linden S, Veys E, Appel AM,<br />
Fatenejad S. Outcomes of a multicentre randomised clinical trial of etanercept to treat<br />
ankylosing spondylitis.Ann Rheum Dis. 2004; 63:1594-600.<br />
176. <strong>Salvarani</strong> C, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L,<br />
Bajocchi G, Catanoso MG, Boiar<strong>di</strong> L. Interleukin-6 promoter polymorphism at position -<br />
174 in giant cell arteritis. J Rheumatol. 2005;32:2173-7.<br />
177. Atzeni F, Sarzi-Puttini P, Doria A, Boiar<strong>di</strong> L, Pipitone N, <strong>Salvarani</strong> C. Behcet's<br />
<strong>di</strong>sease and car<strong>di</strong>ovascular involvement. Lupus. 2005;<strong>14</strong>:723-6.<br />
178. Benucci M, Del Rosso A, Li Gobbi F, Manfre<strong>di</strong> M, Cerinic MM, <strong>Salvarani</strong> C.<br />
Systemic lupus erythematosus (SLE) in Italy: an Italian prevalence study based on a twostep<br />
strategy in an area of Florence (Scan<strong>di</strong>cci-Le Signe). Med Sci Monit. 2005;11:CR420-<br />
5.<br />
179. Cantini F, Niccoli L, Nannini C, Padula A, Olivieri I, Boiar<strong>di</strong> L, <strong>Salvarani</strong> C.<br />
Inflammatory changes of hip synovial structures in polymyalgia rheumatica.Clin Exp<br />
Rheumatol. 2005;23:462-8.<br />
180. Vaglio A, Greco P, Versari A, Filice A, Cobelli R, Manenti L, <strong>Salvarani</strong> C, Buzio C.<br />
Post-treatment residual tissue in i<strong>di</strong>opathic retroperitoneal fibrosis: active residual <strong>di</strong>sease<br />
or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography.<br />
Clin Exp Rheumatol. 2005;23:231-4.<br />
181. Pipitone N, Boiar<strong>di</strong> L, <strong>Salvarani</strong> C. Are steroids alone sufficient for the treatment of<br />
giant cell arteritis? Best Pract Res Clin Rheumatol. 2005;19:277-92.<br />
182. <strong>Salvarani</strong> C, Cimino L, Macchioni P, Consonni D, Cantini F, Bajocchi G, Pipitone N,<br />
Catanoso MG, Boiar<strong>di</strong> L. Risk factors for visual loss in an Italian population-based cohort<br />
of patients with giant cell arteritis. Arthritis Rheum. 2005;53:293-7.<br />
183. <strong>Salvarani</strong> C, Pipitone N, Versari A, Vaglio A, Serafini D, Bajocchi G, Salvo D, Buzio<br />
C, Greco P, Boiar<strong>di</strong> L. Positron emission tomography (PET): evaluation of chronic<br />
periaortitis.Arthritis Rheum. 2005;53:298-303.<br />
184. Vanoli M, Daina E, <strong>Salvarani</strong> C, Sabba<strong>di</strong>ni MG, Rossi C, Bacchiani G, Schieppati A,<br />
Bal<strong>di</strong>ssera E, Bertolini G; Itaka Study Group. Takayasu's arteritis: A study of 104 Italian<br />
patients. Arthritis Rheum. 2005;53:100-7.<br />
16
17<br />
185. <strong>Salvarani</strong> C, Cantini F, Niccoli L, Macchioni P, Consonni D, Bajocchi G, Vinceti M,<br />
Catanoso MG, Pulsatelli L, Meliconi R, Boiar<strong>di</strong> L. Acute-phase reactants and the risk of<br />
relapse/recurrence in polymyalgia rheumatica: a prospective followup study. Arthritis<br />
Rheum. 2005; 53:33-8.<br />
186. Vaglio A, Versari A, Fraternali A, Ferrozzi F, <strong>Salvarani</strong> C, Buzio C. (18)Ffluorodeoxyglucose<br />
positron emission tomography in the <strong>di</strong>agnosis and followup of<br />
i<strong>di</strong>opathic retroperitoneal fibrosis. Arthritis Rheum. 2005;53:122-5.<br />
187. Pipitone N, <strong>Salvarani</strong> C. Systemic vasculitis: state of the art and emerging concepts.<br />
Curr Opin Rheumatol. 2006;18:1-2.<br />
188. Pipitone N, Olivieri I, Cantini F, Triolo G, <strong>Salvarani</strong> C. New approaches in the<br />
treatment of Adamantiades-Behçet's <strong>di</strong>sease. Curr Opin Rheumatol. 2006;18:3-9.<br />
189. Vaglio A, <strong>Salvarani</strong> C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006; 367:241-51.<br />
190. Martorana D, Vaglio A, Greco P, Zanetti A, Moroni G, <strong>Salvarani</strong> C, Savi M, Buzio C,<br />
Neri TM. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin.<br />
Arthritis Rheum. 2006;55:126-30.<br />
191. Griffiths CE, Iaccarino L, Nal<strong>di</strong> L, Olivieri I, Pipitone N, <strong>Salvarani</strong> C, Doria A. Psoriasis<br />
and psoriatic arthritis: immunological aspects and therapeutic guidelines. Clin Exp<br />
Rheumatol. 2006;24(1 Suppl 40):S72-8.<br />
192. <strong>Salvarani</strong> C, Olivieri I, Pipitone N, Cantini F, Marchesoni A, Punzi L, Scarpa R,<br />
Matucci-Cerinic M; Italian Society for Rheumatology. Recommendations of the Italian<br />
Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the<br />
treatment of psoriatic arthritis. Clin Exp Rheumatol. 2006;24:70-8.<br />
193. Boiar<strong>di</strong> L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi<br />
G, Catanoso MG, Pulsatelli L, Consonni D, <strong>Salvarani</strong> C. Relationship Between Interleukin<br />
6 Promoter Polymorphism at Position -174, IL-6 Serum Levels, and the Risk of<br />
Relapse/Recurrence in Polymyalgia Rheumatica. J Rheumatol. 2006; 33: 703-8.<br />
194. Chen Q, Casali B, Pattacini L, Boiar<strong>di</strong> L, <strong>Salvarani</strong> C. Tumor necrosis factor-alpha<br />
protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3kinase<br />
Akt signal transduction. J Rheumatol. 2006; 33: 1061-8.<br />
195. Pipitone N, Masini L, <strong>Salvarani</strong> C. A case of arthritis and vasculitis associated with<br />
the refractory anemia with excess of blasts syndrome resistant to glucocorticoid treatment<br />
that responded favorably to TNF-alpha blockade. Clin Exp Rheumatol. 2006;24 (2 Suppl<br />
41):S31-4.<br />
196. Pipitone N, Boiar<strong>di</strong> L, Bajocchi G, <strong>Salvarani</strong> C. Long-term outcome of giant cell<br />
arteritis. Clin Exp Rheumatol. 2006; 24 (2 Suppl 41): S65-70.<br />
197. Cantini F, Niccoli L, Benucci M, Chindamo D, Nannini C, Olivieri I, Padula A,<br />
<strong>Salvarani</strong> C. Switching from infliximab to once-weekly administration of 50 mg etanercept<br />
in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week<br />
17
study. Arthritis Rheum. 2006;55:812-6.<br />
18<br />
198. Boiar<strong>di</strong> L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi<br />
G, Grazia Catanoso M, Pattacini L, <strong>Salvarani</strong> C. Interleukin-10 promoter polymorphisms in<br />
giant cell arteritis. Arthritis Rheum. 2006; 54: 4011-7.<br />
199. <strong>Salvarani</strong> C, Giannini C, Miller DV, Hunder G. Giant cell arteritis: Involvement of<br />
intracranial arteries. Arthritis Rheum. 2006;55:985-9.<br />
200. Pulsatelli L, Dolzani P, Silvestri T, De Giorgio R, <strong>Salvarani</strong> C, Macchioni P, Frizziero<br />
L, Meliconi R. Synovial expression of vasoactive intestinal peptide in polymyalgia<br />
rheumatica.Clin Exp Rheumatol. 2006 Sep-Oct;24(5):562-6.<br />
201. <strong>Salvarani</strong> C, Pipitone N, Catanoso MG, Cimino L, Tumiati B, Macchioni P, Bajocchi<br />
G, Olivieri I, Boiar<strong>di</strong> L. Epidemiology and clinical course of Behcet's <strong>di</strong>sease in the Reggio<br />
Emilia area of Northern Italy: A seventeen-year population-based study. Arthritis Rheum.<br />
2007; 57:171-8.<br />
202. Ghinoi A, Pipitone N, Boiar<strong>di</strong> L, Pizzini A, <strong>Salvarani</strong> C. Primary Sjogren's syndrome<br />
associated with chronic periaortitis. Rheumatology (Oxford). 2007; 46: 719-20.<br />
203. Olivieri I, Garcia-Porrua C, Padula A, Cantini F, <strong>Salvarani</strong> C, Gonzalez-Gay MA. Late<br />
onset un<strong>di</strong>fferentiated spondyloarthritis presenting with polymyalgia rheumatica features:<br />
description of seven cases. Rheumatol Int. 2007; 27:927-33.<br />
204. Bajocchi G, Zamorani G, Cavazza A, Pipitone N, Versari A, Boiar<strong>di</strong> L, <strong>Salvarani</strong> C.<br />
Giant-cell arteritis of the female genital tract associated with occult temporal arteritis and<br />
FDG-PET evidence of large-vessel vasculitis. Clin Exp Rheumatol. 2007; 25 Suppl 44(1):<br />
36-39.<br />
205. Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, <strong>Salvarani</strong><br />
C, Xu W, Visvanathan S, Rahman MU; Infliximab-GCA Study Group. Infliximab for<br />
maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized<br />
trial. Ann Intern Med. 2007;<strong>14</strong>6:621-30.<br />
206. <strong>Salvarani</strong> C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino<br />
M, Gerli R, Catanoso MG, Boiar<strong>di</strong> L, Cantini F, Klersy C, Hunder GG. Infliximab plus<br />
prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica:<br />
a randomized trial. Ann Intern Med. 2007; <strong>14</strong>6: 631-9.<br />
207. Niccoli L, Nannini C, Benucci M, Chindamo D, Cassarà E, <strong>Salvarani</strong> C, Cimino L,<br />
Gini G, Lenzetti I, Cantini F. Long-term efficacy of infliximab in refractory posterior uveitis<br />
of Behcet's <strong>di</strong>sease: a 24-month follow-up study. Rheumatology (Oxford). 2007;46:1161-4.<br />
208. Macchioni P, Nicoli D, Casali B, Catanoso M, Farnetti E, Boiar<strong>di</strong> L, <strong>Salvarani</strong> C. The<br />
codon 72 polymorphic variants of p53 in Italian rheumatoid arthritis patients. Clin Exp<br />
Rheumatol. 2007; 25: 416-21.<br />
209. Pattacini L, Casali B, Boiar<strong>di</strong> L, Pipitone N, Albertazzi L, <strong>Salvarani</strong> C. Angiotensin II<br />
protects fibroblast-like synoviocytes from apoptosis via the AT1-NF-kappaB pathway.<br />
18
Rheumatology (Oxford). 2007; 46: 1252-7.<br />
210. Pulsatelli L, Dolzani P, Silvestri T, Boiar<strong>di</strong> L, <strong>Salvarani</strong> C, Macchioni P, Facchini A,<br />
Meliconi R. Circulating RANKL/OPG in polymyalgia rheumatica. Clin Exp Rheumatol.<br />
2007; 25: 621-3.<br />
211. Cantini F, Niccoli L, Nannini C, Chindamo D, Bertoni M, Cassarà E, <strong>Salvarani</strong> C.<br />
Isolated knee monoarthritis heral<strong>di</strong>ng resectable non-small-cell lung cancer. A<br />
paraneoplastic syndrome not previously described. Ann Rheum Dis. 2007; 66:1672-4.<br />
19<br />
212. Atzeni F, Boiar<strong>di</strong> L, Casali B, Farnetti E, Sarzi-Puttini P, Pipitone N, Olivieri I, Cantini<br />
F, Salvi F, La Corte R, Triolo G, Filippini D, Paolazzi G, <strong>Salvarani</strong> C. Lack of association of<br />
the -463 G/A myeloperoxidase promoter polymorphism with Behcet's <strong>di</strong>sease in Italian<br />
patients. Rheumatology (Oxford). 2007; 46: 1547-50.<br />
213. <strong>Salvarani</strong> C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV,<br />
Giannini C, Meschia JF, Huston J 3rd, Hunder GG. Primary central nervous system<br />
vasculitis: analysis of 101 patients. Ann Neurol. 2007; 62:442-51.<br />
2<strong>14</strong>. <strong>Salvarani</strong> C, Casali B, Farnetti E, Pipitone N, Formisano D, Nicoli D, Macchioni P,<br />
Cimino L, Bajocchi G, Grazia Catanoso M, Restuccia G, Ghinoi A, Boiar<strong>di</strong> L. PlA1/A2<br />
polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic<br />
complications in giant cell arteritis. Arthritis Rheum. 2007; 56:3502-8.<br />
215. Catanoso MG, Macchioni P, Boiar<strong>di</strong> L, Pipitone N, <strong>Salvarani</strong> C. Treatment of<br />
refractory polymyalgia reumatica with etanercept: an open pilot study. Arthritis Rheum.<br />
2007; 57: 15<strong>14</strong>-9.<br />
216. Vaglio A, Palmisano A, Corra<strong>di</strong> D, <strong>Salvarani</strong> C, Buzio C. Retroperitoneal fibrosis:<br />
evolving concepts. Rheum Dis Clin North Am. 2007;33:803-17.<br />
217. <strong>Salvarani</strong> C, Pipitone N, Catanoso MG. Clinical assessment in psoriatic arthritis.<br />
Reumatismo. 2007;59 Suppl 1:68-72.<br />
218. Pipitone N, <strong>Salvarani</strong> C. Established and new treatments of the i<strong>di</strong>opathic<br />
inflammatory myopathies: dermatomyositis and polymyositis. Clin Exp Rheumatol.<br />
2007;25:896-906.<br />
219. <strong>Salvarani</strong> C, Hunder GG. Tumor necrosis factor blocking agents in polymyalgia<br />
rheumatica and giant cell arteritis. Ann Intern Med. 2008; <strong>14</strong>8:167-8.<br />
220. <strong>Salvarani</strong> C, Brown RD, Calamia KT, Huston III J, Meschia JF, Giannini C, Miller DV,<br />
Hunder GG. Efficacy of TNF-α blockade in primary central nervous system vasculitis<br />
resistant to immunosuppressive treatment. Arthritis Rheum 2008; 59:291-6.<br />
221. <strong>Salvarani</strong> C, Brown RD, Calamia KT, Christianson TJH, Huston III J, Meschia JF,<br />
Giannini C, Miller DV, Hunder GG. Primary central nervous system vasculitis with<br />
prominent leptomeningeal enhancement. A subset with a benign outcome. Arthritis Rheum<br />
2008; 58:595-603.<br />
19
222. Pipitone N, Olivieri I, Padula A, D’Angelo S, Nigro A, Zuccoli G, <strong>Salvarani</strong> C.<br />
Infliximab for the treatment of Neuro-Behçet’s <strong>di</strong>sease: a case series and review of the<br />
literature. Arthritis Rheum 2008; 59:285-90.<br />
223. Pipitone N, <strong>Salvarani</strong> C. Improving therapeutic options for patients with giant cell<br />
arteritis. Curr Opinion Rheumatol 2008; 20:17-22.<br />
224. Vaglio A, Palmisano A, Ferretti S, Alberici F, Casazza L, <strong>Salvarani</strong> C, Buzio C.<br />
Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases<br />
and review of the literature. Rheumatology (Oxford) 2008; 47:315-8.<br />
225. D' Angelo S, Padula A, Nigro A, Cantini F, Matucci-Cerinic M, Modena V, Punzi L,<br />
<strong>Salvarani</strong> C, Scarpa R, Olivieri I. Italian evidence-based recommendations for the<br />
management of ankylosing spondylitis: the 3E Initiative in Rheumatology. Clin Exp<br />
Rheumatol. 2008; 26:1005-11.<br />
20<br />
226. Pipitone N, <strong>Salvarani</strong> C. Role of imaging in vasculitis and connective tissue <strong>di</strong>seases.<br />
Best Pract Res Clin Rheumatol. 2008; 22:1075-91. Review.<br />
227. Pipitone N, Macchioni P, Zuccoli G, <strong>Salvarani</strong> C. Focal myositis of the calf muscles.<br />
Clin Exp Rheumatol. 2008; 26:970-1.<br />
228. Pipitone N, <strong>Salvarani</strong> C. The role of infectious agents in the pathogenesis of<br />
vasculitis. Best Pract Res Clin Rheumatol. 2008; 22:897-911. Review.<br />
229. <strong>Salvarani</strong> C, Brown RD Jr, Huston J 3rd, Hunder GG. Prominent perivascular<br />
enhancement in primary central nervous system vasculitis. Clin Exp Rheumatol. 2008;<br />
26(3 Suppl 49):S111.<br />
230. Ghinoi A, Pipitone N, Nicolini A, <strong>Salvarani</strong> C. Cranial giant cell arteritis evolving into<br />
early large-vessel vasculitis. Clin Exp Rheumatol. 2008; 26(3 Suppl 49):S97-100.<br />
231. Ghinoi A, Zuccoli G, Nicolini A, Pipitone N, Macchioni L, Bajocchi GL, Nicoli F,<br />
Silingar<strong>di</strong> M, Catanoso MG, Boiar<strong>di</strong> L, <strong>Salvarani</strong> C. 1T magnetic resonance imaging in the<br />
<strong>di</strong>agnosis of giant cell arteritis: comparison with ultrasonography and physical examination<br />
of temporal arteries. Clin Exp Rheumatol. 2008; 26(3 Suppl 49):S76-80.<br />
232. Vaglio A, Corra<strong>di</strong> D, Maestri R, Callegari S, Buzio C, <strong>Salvarani</strong> C. Pericar<strong>di</strong>tis<br />
heral<strong>di</strong>ng Erdheim-Chester <strong>di</strong>sease. Circulation. 2008; 118:e511-2.<br />
233. <strong>Salvarani</strong> C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF,<br />
Giannini C, iller DV, Hunder GG. Angiography-negative primary central nervous system<br />
vasculitis: a syndrome involving small cerebral vessels. Me<strong>di</strong>cine (Baltimore). 2008;<br />
87:264-71.<br />
234. Pipitone N, Ghinoi A, Versari A, Vaglio A, Palmisano A, <strong>Salvarani</strong> C. Images in<br />
car<strong>di</strong>ovascular me<strong>di</strong>cine. Chronic periaortitis. Circulation. 2008; 118:12<strong>14</strong>-6.<br />
235. <strong>Salvarani</strong> C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF,<br />
Giannini C, Miller DV, Hunder GG. Primary central nervous system vasculitis: comparison<br />
20
of patients with and without cerebral amyloid angiopathy. Rheumatology (Oxford). 2008,<br />
47:1671-7.<br />
21<br />
236. Olivieri I, de Portu S, <strong>Salvarani</strong> C, Cauli A, Lubrano E, Spadaro A, Cantini F, Cutro<br />
MS, Mathieu A, Matucci-Cerinic M, Pappone N, Punzi L, Scarpa R, Mantovani LG; PACE<br />
working group.The psoriatic arthritis cost evaluation study: a cost-of-illness study on<br />
tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to<br />
conventional therapy. Rheumatology (Oxford). 2008; 47:1664-70.<br />
237. Pulsatelli L, Boiar<strong>di</strong> L, Pignotti E, Dolzani P, Silvestri T, Macchioni P, Cantini F,<br />
<strong>Salvarani</strong> C, Facchini A, Meliconi R. Serum interleukin-6 receptor in polymyalgia<br />
rheumatica: a potential marker of relapse/recurrence risk. Arthritis Rheum. 2008;<br />
59:1<strong>14</strong>7-54.<br />
238. <strong>Salvarani</strong> C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell<br />
arteritis.Lancet. 2008; 372:234-45. Review.<br />
239. Boehncke WH, Adebajo A, Cauli A, Nash P, <strong>Salvarani</strong> C, Kavanaugh AF. Initiative for<br />
quality in psoriasis and psoriatic arthritis. J Rheumatol. 2008; 35:<strong>14</strong>31-3.<br />
240. Cimmino MA, <strong>Salvarani</strong> C, Macchioni P, Gerli R, Bartoloni Bocci E, Montecucco C,<br />
Caporali R; Systemic Vasculitis Study Group of the Italian Society for Rheumatology.<br />
Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and<br />
steroids. Clin Exp Rheumatol. 2008; 26:395-400.<br />
241. Doria A, Bajocchi G, Tonon M, <strong>Salvarani</strong> C. Pre-pregnancy counselling of patients<br />
with vasculitis. Rheumatology (Oxford). 2008; 47 Suppl 3:iii13-5. Review.<br />
242. <strong>Salvarani</strong> C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF,<br />
Giannini C, Miller DV, Hunder GG. Primary CNS vasculitis with spinal cord involvement.<br />
Neurology. 2008 ; 70:2394-400.<br />
243. Olivieri I, Scarano E, Padula A, D'Angelo S, <strong>Salvarani</strong> C, Cantini F, Niccoli L, Barozzi<br />
L. Fast spin echo-T2-weighted sequences with fat saturation in toe dactylitis of<br />
spondyloarthritis. Clin Rheumatol. 2008; 27:1<strong>14</strong>1-5.<br />
244. Revicki DA, Luo MP, Wordsworth P, Wong RL, Chen N, Davis JC Jr; ATLAS Study<br />
Group. Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing<br />
spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for<br />
ankylosing spondylitis (ATLAS). J Rheumatol. 2008; 35:1346-53.<br />
245. <strong>Salvarani</strong> C, Pipitone N, Boiar<strong>di</strong> L, Hunder GG. Do we need treatment with tumour<br />
necrosis factor blockers for giant cell arteritis? Ann Rheum Dis. 2008;67:577-9.<br />
246. Cantini F, Niccoli L, Nannini C, Cassarà E, Pasquetti P, Olivieri I, <strong>Salvarani</strong> C.<br />
Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis<br />
requiring second-line drugs. Rheumatology (Oxford). 2008; 47:872-6.<br />
247. Cantini F, Niccoli L, Nannini C, Bertoni M, <strong>Salvarani</strong> C. Diagnosis and treatment of<br />
giant cell arteritis. Drugs Aging. 2008;25:281-97. Review.<br />
21
248. Pipitone N, Versari A, <strong>Salvarani</strong> C. Role of imaging stu<strong>di</strong>es in the <strong>di</strong>agnosis and<br />
follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford). 2008; 47:403-8.<br />
Review.<br />
249. Pipitone N, <strong>Salvarani</strong> C. Improving therapeutic options for patients with giant cell<br />
arteritis. Curr Opin Rheumatol. 2008; 20:17-22. Review.<br />
22<br />
250. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH,<br />
Kötter I, Olivieri I, <strong>Salvarani</strong> C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S,<br />
Yazici H; EULAR Expert Committee. EULAR recommendations for the management of<br />
Behçet <strong>di</strong>sease. Ann Rheum Dis. 2008; 67:1656-62.<br />
251. Pipitone N, Olivieri I, Padula A, D'angelo S, Nigro A, Zuccoli G, Boiar<strong>di</strong> L, <strong>Salvarani</strong><br />
C. Infliximab for the treatment of Neuro-Behçet's <strong>di</strong>sease: a case series and review of the<br />
literature. Arthritis Rheum. 2008; 59:285-90. Review.<br />
252. Vaglio A, Palmisano A, Ferretti S, Alberici F, Casazza I, <strong>Salvarani</strong> C, Buzio C.<br />
Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases<br />
and review of the literature. Rheumatology (Oxford). 2008; 47:315-8.<br />
253. <strong>Salvarani</strong> C, Barozzi L, Cantini F, Niccoli L, Boiar<strong>di</strong> L, Valentino M, Pipitone N,<br />
Bajocchi G, Macchioni P, Catanoso MG, Olivieri I, Hunder GG. Cervical interspinous<br />
bursitis in active polymyalgia rheumatica. Ann Rheum Dis. 2008; 67:758-61.<br />
254. <strong>Salvarani</strong> C, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni PL, Cimino L,<br />
Bajocchi GL et al. -463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis.<br />
Ann Rheum Dis 2008; 67:485-8<br />
255. Helliwell PS, Taylor WJ; CASPAR Study Group. Treatment of psoriatic arthritis and<br />
rheumatoid arthritis with <strong>di</strong>sease mo<strong>di</strong>fying drugs -- comparison of drugs and adverse<br />
reactions.J Rheumatol. 2008; 35:472-6.<br />
256. <strong>Salvarani</strong> C, Hunder GG. Tumor necrosis factor blocking agents in polymyalgia<br />
rheumatica and giant cell arteritis.<br />
Ann Intern Med. 2008; <strong>14</strong>8:167-8;<br />
257. Dasgupta B, <strong>Salvarani</strong> C, Schirmer M, Crowson CS, Mara<strong>di</strong>t-Kremers H, Hutchings<br />
A, Matteson EL; members of the American College of Rheumatology Work Group for<br />
Development of Classification Criteria for PMR. Developing classification criteria for<br />
polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J<br />
Rheumatol. 2008; 35:270-7.<br />
258. Lubrano E, Marchesoni A, Olivieri I, D'Angelo S, Spadaro A, Parsons WJ, Cauli A,<br />
<strong>Salvarani</strong> C, Mathieu A, Zaccara E, Ferrara N, Helliwell PS. The ra<strong>di</strong>ological assessment<br />
of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the<br />
mo<strong>di</strong>fied SASSS scoring methods. Clin Exp Rheumatol. 2009; 27:977-80.<br />
259. Olivieri I, Pipitone N, D' Angelo S, Padula A, <strong>Salvarani</strong> C. Late-onset rheumatoid<br />
arthritis and late-onset spondyloarthritis. Clin Exp Rheumatol. 2009; 27(4 Suppl 55):S139-<br />
22
45.<br />
23<br />
260. Boiar<strong>di</strong> L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi<br />
GL, Catanoso MG, Pattacini L, Ghinoi A, Restuccia G, <strong>Salvarani</strong> C. Toll-like receptor 4<br />
(TLR4) gene polymorphisms in giant cell arteritis. Clin Exp Rheumatol. 2009;27(1 Suppl<br />
52):S40-4.<br />
261. Boiar<strong>di</strong> L, Atzeni F, Casali B, Farnetti E, Nicoli D, Pipitone N, Catanoso MG, Olivieri I,<br />
Cantini F, Salvi F, La Corte R, Triolo G, Filippini D, Paolazzi G, <strong>Salvarani</strong> C. Toll-like<br />
receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet's <strong>di</strong>sease. Clin Exp<br />
Rheumatol. 2009; 27(2 Suppl 53):S43-7.<br />
262. Ghinoi A, Boiar<strong>di</strong> L, Atzeni F, Casali B, Farnetti E, Nicoli D, Pipitone N, Olivieri I,<br />
Cantini F, Salvi F, La Corte R, Triolo G, Filippini D, Paolazzi G, <strong>Salvarani</strong> C. Protein Z<br />
G79A and A-13G gene polymorphisms in Italian patients with Behçet's <strong>di</strong>sease. Clin Exp<br />
Rheumatol. 2009; 27(2 Suppl 53):S23-8.<br />
263. Marchesoni A, Altomare G, Matucci-Cerinic M, Balato N, Olivieri I, <strong>Salvarani</strong> C, Lotti<br />
T, Scarpa R, Vena G, Valesini G, Giannetti A. An Italian shared dermatological and<br />
rheumatological proposal for the use of biological agents in psoriatic <strong>di</strong>sease. J Eur Acad<br />
Dermatol Venereol. 2009 Oct 23. [Epub ahead of print]<br />
264. Macchioni P, Catanoso MG, Pipitone N, Boiar<strong>di</strong> L, <strong>Salvarani</strong> C. Longitu<strong>di</strong>nal<br />
examination with shoulder ultrasound of patients with polymyalgia rheumatica.<br />
Rheumatology (Oxford). 2009; 48:1566-9.<br />
265. Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, Kavanaugh A,<br />
Krueger GG, Langley RG, Lynde C, McHugh N, Mease P, Olivieri I, Rahman P, Rosen<br />
CF, <strong>Salvarani</strong> C, Thaci D, Toloza SM, Wong MY, Zhou QM, Gladman DD. International<br />
multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints,<br />
nails, and dactylitis. Arthritis Rheum. 2009; 61:1235-42.<br />
266. Cantini F, Niccoli L, Nannini C, Cassarà E, Pasquetti P, Olivieri I, <strong>Salvarani</strong> C.<br />
Criteria, frequency, and duration of clinical remission in psoriatic arthritis patients with<br />
peripheral involvement requiring second-line drugs. J Rheumatol Suppl. 2009; 83:78-80.<br />
267. <strong>Salvarani</strong> C, Boiar<strong>di</strong> L, Macchioni P, Pipitone N, Catanoso M, Pigatto P.<br />
Multi<strong>di</strong>sciplinary focus on cyclosporin A. J Rheumatol Suppl. 2009; 83:52-5.<br />
268. Nannini C, Cantini F, Niccoli L, Cassarà E, <strong>Salvarani</strong> C, Olivieri I, Lally EV. Singlecenter<br />
series and systematic review of randomized controlled trials of malignancies in<br />
patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving<br />
anti-tumor necrosis factor alpha therapy: is there a need for more comprehensive<br />
screening procedures? Arthritis Rheum. 2009; 61:801-12. Review.<br />
269. <strong>Salvarani</strong> C, Fries W. Clinical features and epidemiology of spondyloarthritides<br />
associated with inflammatory bowel <strong>di</strong>sease. World J Gastroenterol. 2009; 15:2449-55.<br />
Review.<br />
270. Dijkmans B, Emery P, Hakala M, Leirisalo-Repo M, Mola EM, Paolozzi L, <strong>Salvarani</strong><br />
C, Sanmarti R, Sibilia J, Sieper J, Van Den Bosch F, van der Heijde D, van der Linden S,<br />
23
24<br />
Wajdula J. Etanercept in the longterm treatment of patients with ankylosing spondylitis. J<br />
Rheumatol. 2009; 36:1256-64.<br />
271. Lubrano E, Marchesoni A, Olivieri I, D'Angelo S, Spadaro A, Parsons WJ, Cauli A,<br />
<strong>Salvarani</strong> C, Mathieu A, Porter G, Helliwell PS. Psoriatic arthritis spondylitis ra<strong>di</strong>ology<br />
index: a mo<strong>di</strong>fied index for ra<strong>di</strong>ologic assessment of axial involvement in psoriatic arthritis.<br />
J Rheumatol. 2009; 36:1006-11.<br />
272. <strong>Salvarani</strong> C, Della Bella C, Cimino L, Macchioni P, Formisano D, Bajocchi G,<br />
Pipitone N, Catanoso MG, Restuccia G, Ghinoi A, Boiar<strong>di</strong> L. Risk factors for severe cranial<br />
ischaemic events in an Italian population-based cohort of patients with giant cell arteritis.<br />
Rheumatology (Oxford). 2009; 48(3):250-3.<br />
273. Lubrano E, Marchesoni A, Olivieri I, D'Angelo S, Spadaro A, Parsons WJ, Cauli A,<br />
<strong>Salvarani</strong> C, Mathieu A, Zaccara E, Ferrara N, Helliwell PS. The ra<strong>di</strong>ological assessment<br />
of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the<br />
mo<strong>di</strong>fied SASSS scoring methods. Clin Exp Rheumatol. 2009; 27:977-80.<br />
274. Olivieri I, Pipitone N, D' Angelo S, Padula A, <strong>Salvarani</strong> C. Late-onset rheumatoid<br />
arthritis and late-onset spondyloarthritis. Clin Exp Rheumatol. 2009; 27(4 Suppl 55):S139-<br />
45.<br />
275. van der Heijde D, Schiff MH, Sieper J, Kivitz AJ, Wong RL, Kupper H, Dijkmans BA,<br />
Mease PJ, Davis JC Jr; ATLAS Study Group. Adalimumab effectiveness for the treatment<br />
of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS<br />
trial. Ann Rheum Dis. 2009; 68:922-9.<br />
276. Miller DV, <strong>Salvarani</strong> C, Hunder GG, Brown RD, Parisi JE, Christianson TJ, Giannini<br />
C. Biopsy fin<strong>di</strong>ngs in primary angiitis of the central nervous system. Am J Surg Pathol.<br />
2009 ; 33:35-43.<br />
277. Boiar<strong>di</strong> L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi<br />
GL, Catanoso MG, Pattacini L, Ghinoi A, Restuccia G, <strong>Salvarani</strong> C. Toll-like receptor 4<br />
(TLR4) gene polymorphisms in giant cell arteritis. Clin Exp Rheumatol. 2009;27(1 Suppl<br />
52):S40-4.<br />
278. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH,<br />
Kötter I, Olivieri I, <strong>Salvarani</strong> C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S,<br />
Yazici H. Management of Behçet <strong>di</strong>sease: a systematic literature review for the European<br />
League Against Rheumatism evidence-based recommendations for the management of<br />
Behçet <strong>di</strong>sease. Ann Rheum Dis. 2009; 68:1528-34. Review.<br />
279. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T,<br />
Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, <strong>Salvarani</strong> C, Scott DG,<br />
Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis<br />
Study Group. EULAR recommendations for the management of primary small and<br />
me<strong>di</strong>um vessel vasculitis. Ann Rheum Dis. 2009; 68:310-7.<br />
280. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T,<br />
Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, <strong>Salvarani</strong> C, Scott DG,<br />
Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis<br />
24
Study Group. EULAR recommendations for the management of large vessel vasculitis.<br />
Ann Rheum Dis. 2009; 68:318-23.<br />
25<br />
281. Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, Brogan P, Calabrese L, Cid<br />
MC, Cohen-Tervaert JW, Flores-Suarez LF, Fujimoto S, de Groot K, Guillevin L, Hatemi<br />
G, Hauser T, Jayne D, Jennette C, Kallenberg CG, Kobayashi S, Little MA, Mahr A,<br />
McLaren J, Merkel PA, Ozen S, Puechal X, Rasmussen N, Salama A, <strong>Salvarani</strong> C,<br />
Savage C, Scott DG, Segelmark M, Specks U, Sunderköetter C, Suzuki K, Tesar V, Wiik<br />
A, Yazici H, Luqmani R. EULAR points to consider in the development of classification and<br />
<strong>di</strong>agnostic criteria in systemic vasculitis. Ann Rheum Dis. 2010 May 6. [Epub ahead of<br />
print]<br />
282. Cimino L, Boiar<strong>di</strong> L, Al<strong>di</strong>geri R, Casali B, Nicoli D, Farnetti E, <strong>Salvarani</strong> C, Cirone D,<br />
De Martino L, Pupino A, Cappuccini L. G/R 241 polymorphism of intercellular adhesion<br />
molecule 1 (ICAM-1) is associated with Fuchs uveitis. Invest Ophthalmol Vis Sci. 2010<br />
May 5. [Epub ahead of print]<br />
283. <strong>Salvarani</strong> C, Calamia KT, Crowson CS, Miller DV, Broadwell AW, Hunder GG,<br />
Matteson EL, Warrington KJ. Localized vasculitis of the gastrointestinal tract: a case<br />
series. Rheumatology (Oxford). 2010 Apr 1. [Epub ahead of print]<br />
284. Cimino L, Al<strong>di</strong>geri R, <strong>Salvarani</strong> C, Zotti CA, Boiar<strong>di</strong> L, Parmeggiani M, Casali B,<br />
Cappuccini L. The causes of uveitis in a referral centre of Northern Italy. Int Ophthalmol.<br />
2010 Mar <strong>14</strong>. [Epub ahead of print]<br />
285. Spadaro A, Punzi L, Marchesoni A, Lubrano E, Mathieu A, Cantini F, Olivieri I,<br />
<strong>Salvarani</strong> C, Scarpa R, Scrivo R, Ramonda R, Porru G, D'Angelo S, Catanoso M, Atteno<br />
M, Valesini G. Switching from infliximab or etanercept to adalimumab in resistant or<br />
intolerant patients with spondyloarthritis: a 4-year study. Rheumatology (Oxford) 2010;<br />
49:1107-11.<br />
286. Scarpa R, Altomare G, Marchesoni A, Balato N, Matucci Cerinic M, Lotti T, Olivieri I,<br />
Vena GA, <strong>Salvarani</strong> C, Valesini G, Giannetti A. Psoriatic <strong>di</strong>sease: concepts and<br />
implications. J Eur Acad Dermatol Venereol. 2010 Feb 25. [Epub ahead of print].<br />
287. Pattacini L, Boiar<strong>di</strong> L, Casali B, <strong>Salvarani</strong> C. Differential effects of anti-TNF-alpha<br />
drugs on fibroblast-like synoviocyte apoptosis. Rheumatology (Oxford). 2010; 49:480-9.<br />
288. Pipitone N, <strong>Salvarani</strong> C, Peter HH. [Chronic periaortitis]. Internist (Berl). 2010 Jan;<br />
51:45-52. German.<br />
289. Scarpato S, Antivalle M, Favalli EG, Nacci F, Frigelli S, Bartoli F, Bazzichi L, Minisola<br />
G, Matucci Cerinic M; RIVIERA co-authors. Patient preferences in the choice of anti-TNF<br />
therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study).<br />
Rheumatology (Oxford). 2010; 49:289-94.<br />
290. Rubbert-Roth A, Tak PP, Zerbini C, Tremblay JL, Carreño L, Armstrong G, Collinson<br />
N, Shaw TM; MIRROR Trial Investigators. Efficacy and safety of various repeat treatment<br />
dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase<br />
III randomized study (MIRROR). Rheumatology (Oxford) 2010; 49:1683-93.<br />
25
26<br />
291. Dejaco C, Duftner C, Cimmino MA, Dasgupta B, <strong>Salvarani</strong> C, Crowson CS, Mara<strong>di</strong>t-<br />
Kremers H, Hutchings A, Matteson EL, Schirmer M; and members of the International<br />
Work Group for PMR and GCA.<br />
Definition of remission and relapse in polymyalgia rheumatica: data from a literature<br />
search compared with a Delphi-based expert consensus. Ann Rheum Dis. 2010 Dec <strong>14</strong>.<br />
[Epub ahead of print] PMID: 21097803.<br />
292. Hunder GG, <strong>Salvarani</strong> C, Brown RD Jr. Primary central nervous system vasculitis: Is<br />
it a single <strong>di</strong>sease? Ann Neurol 2010; 68:573-4.<br />
293. <strong>Salvarani</strong> C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF,<br />
Giannini C, Miller DV, Hunder GG. Rapidly progressive primary central nervous system<br />
vasculitis. Rheumatology (Oxford) 2010 Oct 19. [Epub ahead of print] PMID: 20959356.<br />
294. Ghinoi A, Zuccoli G, Pipitone N, <strong>Salvarani</strong> C. Anti-neutrophil cytoplasmic antibody<br />
(ANCA)-associated vasculitis involving the central nervous system: case report and review<br />
of the literature.<br />
Clin Exp Rheumatol 2010; 28:759-66. Epub 2010 Oct 22. Review.<br />
PMID: 208227<strong>14</strong>.<br />
295. Pulsatelli L, Peri G, Macchioni P, Boiar<strong>di</strong> L, <strong>Salvarani</strong> C, Cantini F, Mantovani A,<br />
Meliconi R. Serum levels of long pentraxin PTX3 in patients with polymyalgia rheumatica.<br />
Clin Exp Rheumatol 2010; 28:756-8. Epub 2010 Oct 22.<br />
PMID: 20822713.<br />
296. Magnani A, Pattacini L, Boiar<strong>di</strong> L, Casali B, <strong>Salvarani</strong> C. Reelin levels are increased<br />
in synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2010; 28:546-8.<br />
Epub 2010 Aug 30. PMID: 20659411.<br />
297. Vaglio A, Pipitone N, <strong>Salvarani</strong> C. Chronic periaortitis: a large-vessel vasculitis? Curr<br />
Opin Rheumatol 2011; 23(1):1-6.<br />
298. Ciccia F, Alessandro R, Rizzo A, Principe S, Raiata F, Cavazza A, Guggino G,<br />
Accardo-Palumbo A, Boiar<strong>di</strong> L, Ferrante A, Principato A, Giar<strong>di</strong>na A, De Leo G, <strong>Salvarani</strong><br />
C, Triolo G. Expression of interleukin-32 in the inflamed arteries of patients with giant cell<br />
arteritis. Arthritis Rheum. 2011 Jul;63(7):2097-104. doi: 10.1002/art.30374.<br />
299. Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP, Sardu C, Ujfalussy I,<br />
Scarpa R, Marchesoni A, Taylor WJ, Spadaro A, Fernàndez-Sueiro JL, <strong>Salvarani</strong> C,<br />
Kalden JR, Lubrano E, Carneiro S, Desiati F, Flynn JA, D'Angelo S, Vacca A, VAN Kuijk<br />
AW, Catanoso MG, Gruenke M, Peluso R, Parsons WJ, Ferrara N, Contu P, Helliwell PS,<br />
Mease PJ; GRAPPA 3PPsA Study Group. Patient global assessment in psoriatic arthritis:<br />
a multicenter GRAPPA and OMERACT study. J Rheumatol. 2011 May;38(5):898-903.<br />
Epub 2011 Feb 15.<br />
300. Boiar<strong>di</strong> L, Vaglio A, Nicoli D, Farnetti E, Palmisano A, Pipitone N, Maritati F, Casali B,<br />
Martorana D, Moroni G, Gallelli B, Buzio C, <strong>Salvarani</strong> C. CC chemokine receptor 5<br />
polymorphism in chronic periaortitis. Rheumatology (Oxford). 2011 Jun;50(6):1025-32.<br />
Epub 2011 Jan 21.<br />
26
301. <strong>Salvarani</strong> C, Pipitone N, Marchesoni A, Cantini F, Cauli A, Lubrano E, Punzi L,<br />
Scarpa R, Spadaro A, Matucci-Cerinic M, Olivieri I. Recommendations for the use of<br />
biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for<br />
Rheumatology.<br />
Clin Exp Rheumatol. 2011 May-Jun;29(3 Suppl 66):S28-41. Epub 2011 Jul 26.<br />
27<br />
302. Caporali R, Conti F, Alivernini S, Atzeni F, Seriolo B, Cutolo M, Valesini G, Ferraccioli<br />
G, Sarzi-Puttini P, <strong>Salvarani</strong> C, Guiducci S, Zampogna G, Gremese E, Pipitone N, Scrivo<br />
R, Bugatti S, Montecucco C, Matucci-Cerinic M. Recommendations for the use of biologic<br />
therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I.<br />
Efficacy. Clin Exp Rheumatol. 2011 May-Jun;29(3 Suppl 66):S7-<strong>14</strong>. Epub 2011 Jul 26.<br />
303. Restuccia G, Cavazza A, Boiar<strong>di</strong> L, Pipitone N, Macchioni P, Bajocchi G, Catanoso<br />
MG, Muratore F, Ghinoi A, Magnani L, Cimino L, <strong>Salvarani</strong> C. Small-vessel vasculitis<br />
surroun<strong>di</strong>ng an uninflamed temporal artery and isolated vasa vasorum vasculits of the<br />
temporal artery: Two subsets of giant cell arteritis. Arthritis Rheum. 2011 Sep 27. doi:<br />
10.1002/art.33362. [Epub ahead of print]<br />
304. Sawalha AH, Hughes T, Na<strong>di</strong>g A, Yılmaz V, Aksu K, Keser G, Cefle A, Yazıcı A,<br />
Ergen A, Alarcón-Riquelme ME, <strong>Salvarani</strong> C, Casali B, Direskeneli H, Saruhan-Direskeneli<br />
G. A putative functional variant within the ubiquitin-associated domain-containing protein 2<br />
gene (UBAC2) is associated with increased risk of Behçet's <strong>di</strong>sease. Arthritis Rheum.<br />
2011 Aug 30. doi: 10.1002/art.30604. [Epub ahead of print]<br />
305. Germanò G, Versari A, Muratore F, Pipitone N, Bajocchi GL, Catanoso MG,<br />
<strong>Salvarani</strong> C.<br />
Isolated vasculitis of the lower extremities in a patient with polymyalgia rheumatica and<br />
giant cell arteritis. Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S138-9. Epub 2011<br />
May 11. No abstract available.<br />
306. Zuccoli G, Pipitone N, Hal<strong>di</strong>pur A, Brown RD Jr, Hunder G, <strong>Salvarani</strong> C.<br />
Imaging fin<strong>di</strong>ngs in primary central nervous system vasculitis. Clin Exp Rheumatol. 2011<br />
Jan-Feb;29(1 Suppl 64):S104-9. Epub 2011 May 11. Review.<br />
307. <strong>Salvarani</strong> C, Valli R, Boiar<strong>di</strong> L, Pipitone N, Nicoli F, Muratore F. IgG4-associated<br />
sclerosing mesenteritis. Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S79-80. Epub<br />
2011 May 11.<br />
308. <strong>Salvarani</strong> C, Pipitone N. Treatment of large-vessel vasculitis: where do we stand?<br />
Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S3-5. Epub 2011 May 11.<br />
309. Pipitone N, <strong>Salvarani</strong> C. I<strong>di</strong>opathic aortitis: an underrecognized vasculitis.<br />
Arthritis Res Ther. 2011 Jul 22;13(4):119. [Epub ahead of print]<br />
310. Magnani L, Versari A, Salvo D, Casali M, Germanò G, Meliconi R, Pulsatelli L,<br />
27
Formisano D, Bajocchi G, Pipitone N, Boiar<strong>di</strong> L, <strong>Salvarani</strong> C. .[Disease activity<br />
assessment in large vessel vasculitis]. Reumatismo. 2011;63(2):86-90.<br />
28<br />
311. Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R, Ferrozzi F,<br />
Corra<strong>di</strong> D, <strong>Salvarani</strong> C, Buzio C. Prednisone versus tamoxifen in patients with i<strong>di</strong>opathic<br />
retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet. 2011 Jul<br />
23;378(9788):338-46. Epub 2011 Jul 4.<br />
312. Pipitone N, Versari A, Vaglio A, <strong>Salvarani</strong> C. Role of 18F-fluorodeoxyglucose positron<br />
emission tomography in the workup of retroperitoneal fibrosis. Clin Exp Rheumatol. 2011<br />
Jan-Feb;29(1 Suppl 64):S72-8. Epub 2011 May 11.<br />
313. Lubrano E, Spadaro A, Marchesoni A, Olivieri I, Scarpa R, D'Angelo S, <strong>Salvarani</strong> C,<br />
Mathieu A, Cauli A, Ferrara N, Helliwell P. The effectiveness of a biologic agent on axial<br />
manifestations of psoriatic arthritis. A twelve months observational study in a group of<br />
patients treated with etanercept. Clin Exp Rheumatol. 2011 Jan-Feb;29(1):80-4. Epub<br />
2011 Feb 23.<br />
3<strong>14</strong>. <strong>Salvarani</strong> C, Calamia KT, Matteson EL, Hunder GG, Pipitone N, Miller DV,<br />
Warrington KJ.<br />
Vasculitis of the gastrointestinal tract in chronic periaortitis. Me<strong>di</strong>cine (Baltimore). 2011<br />
Jan;90(1):28-39.<br />
315. Palazzi C, <strong>Salvarani</strong> C, D'Angelo S, Olivieri I. Aortitis and periaortitis in ankylosing<br />
spondylitis. Joint Bone Spine. 2011 Oct;78(5):451-5. Epub 2010 Dec 24.<br />
316. Vaglio A, Pipitone N, <strong>Salvarani</strong> C. Chronic periaortitis: a large-vessel vasculitis?<br />
Curr Opin Rheumatol. 2011 Jan;23(1):1-6. Review.<br />
317. Dejaco C, Duftner C, Cimmino MA, Dasgupta B, <strong>Salvarani</strong> C, Crowson CS, Mara<strong>di</strong>t-<br />
Kremers H, Hutchings A, Matteson EL, Schirmer M; International Work Group for PMR<br />
and GCA.<br />
Definition of remission and relapse in polymyalgia rheumatica: data from a literature<br />
search compared with a Delphi-based expert consensus. Ann Rheum Dis. 2011<br />
Mar;70(3):447-53. Epub 2010 Nov 19. Review.<br />
318. Catanoso MG, Pipitone N, Magnani L, Boiar<strong>di</strong> L, <strong>Salvarani</strong>c C. New in<strong>di</strong>cations for<br />
biological terapie. Intern Emerg med 2011; 6 (Suppl 1):S1-S9.<br />
In Pubblicazione<br />
319. <strong>Salvarani</strong> C, Brown RD Jr, Hunder GG. Primary Central Nervous System Vasculitis.<br />
Lancet, Review.<br />
320. <strong>Salvarani</strong> C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF,<br />
28
29<br />
Giannini C, Miller DV, Hunder GG. Primary central nervous system vasculitis presenting<br />
with intracranial hemorrhage. Arthritis Rheum.<br />
321. <strong>Carlo</strong> <strong>Salvarani</strong>, Robert D. Brown Jr, Gene G. Hunder. Adult primary central nervous<br />
system vasculitis: an update. Current Opinion Rheumatol, in press.<br />
Linee guida terapeutiche nazionali/internazionali<br />
1. A cura del Gruppo multi<strong>di</strong>sciplinare sui Farmaci Biologici in Reumatologia Regione<br />
Emilia-Romagna. Trattamento sistemico dell’Artrite Reumatoide nell’adulto con particolare<br />
riferimento ai farmaci biologici. Direzione Generale alla Sanità e alle Politiche Sociali,<br />
Regione Emilia Romagna. Linee guida terapeutiche n.2, marzo 2010.<br />
2. Olivieri I., <strong>Salvarani</strong> C., Cantini F., et al : Recommendations for starting anti- TNF-alpha<br />
in patients with ankylosing spondylitis. Reumatismo; 55 :220-3,2003.<br />
3. <strong>Salvarani</strong> C, Olivieri I, Cantini F, Marchesoni A, Punzi L, Scarpa R, Matucci-Cerinic M.<br />
Recommendations for the appropriate use of anti-TNFalpha therapy in patients with<br />
psoriatic arthritis. Italian Rheumatology Society. Reumatismo. 2004; 56:133-4<br />
4. <strong>Salvarani</strong> C, Olivieri I, Pipitone N, Cantini F, Marchesoni A, Punzi L, Scarpa R,<br />
Matucci-Cerinic M; Italian Society for Rheumatology. Recommendations of the Italian<br />
Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the<br />
treatment of psoriatic arthritis. Clin Exp Rheumatol. 2006;24:70-8.<br />
5. <strong>Salvarani</strong> C, Pipitone N, Marchesoni A, Cantini F, Cauli A, Lubrano E, Punzi L, Scarpa<br />
R, Spadaro A, Matucci-Cerinic M, Olivieri I. Recommendations of the Italian Society for<br />
Rheumatology for the use of biologic (TNF-α blocking) agents in the treatment of psoriatic<br />
arthritis: 2009 update. Clin Exp Rheumatol, in press<br />
6. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich<br />
B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, <strong>Salvarani</strong> C, Scott DG, Stegeman C,<br />
Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis Study Group.<br />
EULAR recommendations for the management of primary small and me<strong>di</strong>um vessel<br />
vasculitis. Ann Rheum Dis. 2009; 68:310-7.<br />
7. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich<br />
B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, <strong>Salvarani</strong> C, Scott DG, Stegeman C,<br />
Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis Study Group.<br />
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis.<br />
2009; 68:318-23.<br />
8. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter<br />
I, Olivieri I, <strong>Salvarani</strong> C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici<br />
H; EULAR Expert Committee. EULAR recommendations for the management of Behçet<br />
<strong>di</strong>sease. Ann Rheum Dis. 2008; 67:1656-62.<br />
Partecipazione a Textbook internazionali <strong>di</strong> Reumatologia<br />
29
30<br />
EULAR Compen<strong>di</strong>um on Rheumatic Diseases. Pipitone N, Hazleman B, <strong>Salvarani</strong> C.<br />
Polymyalgia rheumatica and giant cell arteritis. E<strong>di</strong>tor JWJ Bijlsma. BMJ Publishing Group<br />
and European league Against Rheumatism 2009.<br />
Chapter: Large vessel vasculitis/giant cell arteritis. Oxford Textbook of Rheumatology 4 th<br />
e<strong>di</strong>tion. E<strong>di</strong>tors: Richard Watts, Philip Conaghan, Christopher Denton, Helen Foster, John<br />
Isaacs & Ulf Müller-Ladner. In press.<br />
Progetti ricerca finalizzata 2009 finanziati:<br />
Principale investigatore del progetto proposto dalla Regione Emilia Romagna dal titolo: “<br />
Diagnosis and treatmet of inflammatory arthropathies in the Regione Emilia Romagna: a<br />
prospective population-based study”.<br />
Progetti ricerca finalizzata 2010 proposti:<br />
Principale investigatore del progetto: Epigenetic determinants of psoriasis and psoriasi<br />
arthritis: <strong>di</strong>agnostic and prognostic values of DNA methylation pattern<br />
Partecipazione a corsi, congressi, convegni e seminari<br />
Negli ultimi 10 anni ho sempre partecipato come relatore invitato ai convegni della Società<br />
Italiana <strong>di</strong> Reumatologia (SIR), American College of Rheumatology (Società Americana <strong>di</strong><br />
Reumatologia) e European League Against Rheumatism (EULAR). Sono inoltre stato<br />
invitato a parlare a numerosi corsi o seminari organizzati dalle stesse Società.<br />
30